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A B S T R A C T
Background
Asthma is a common chronic disease worldwide. Inhalers are often prescribed to help control asthma symptoms, improve quality of
life and reduce the risk of exacerbations or flare-ups. However, evidence suggests that many people with asthma do not use their inhaler
correctly. It is therefore important to evaluate whether interventions aimed specifically at improving technique are effective and safe,
and whether use of these interventions translates into improved clinical outcomes.
Objectives
To assess the impact of interventions to improve inhaler technique on clinical outcomes and safety in adults and children with asthma.
Search methods
We searched the Cochrane Airways Trials Register, which contains records compiled from multiple electronic and handsearched
resources. We also searched trial registries and reference lists of primary studies. We conducted the most recent search on 23 November
2016.
Selection criteria
We included studies comparing a group of adults or children with asthma receiving an inhaler technique intervention versus a group
receiving a control or alternative intervention. We included parallel and cluster-randomised trials of any duration conducted in any
setting, and planned to include only the first phase of any cross-over trials identified. We included studies reported as full-text articles,
those published as abstracts only and unpublished data.
Data collection and analysis
Two review authors screened the search results for eligible studies. We extracted outcome data, assessed risk of bias in duplicate and
resolved discrepancies by involving another review author. We grouped studies making similar comparisons by consensus (e.g. all
those comparing enhanced inhaler technique education vs usual care) and conducted meta-analyses only if treatments, participants
and the underlying clinical question were similar enough for pooling to make sense. We analysed dichotomous data as odds ratios,
and continuous data as mean differences or standardised mean differences, all with random-effects models. We described skewed data
narratively. We graded the results and presented evidence in ’Summary of findings’ tables for each comparison. Primary outcomes were
inhaler technique, asthma control and exacerbations requiring at least oral corticosteroids (OCS).
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Main results
This review includes 29 parallel randomised controlled trials (RCTs) (n = 2210), although not all reported relevant or useable data. All
participants had asthma, and follow-up ranged from 2 to 26 weeks. Most studies were at low or unclear risk of selection and attrition
biases and at high risk for biases associated with blinding. We considered most of the evidence to be of low quality owing to these biases
and to imprecision in the estimates of effect.
We classified studies into three comparisons: enhanced face-to-face training session(s), multi-media-delivered inhaler training (e.g.
DVD, computer app or game) and technique feedback devices. Differences between interventions, populations and outcome measures
limited quantitative analyses, particularly for exacerbations, adverse events, unscheduled visits to a healthcare provider and absenteeism
from work or school.
Enhanced inhaler technique education andmulti-media training improved technique inmost studies immediately after the intervention
and at follow-up, although the variety of checklists used meant that this was difficult to assess reliably. For both adults and children,
how and when inhaler technique was assessed appeared to affect whether inhaler technique improved and by how much.
Analyses of the numbers of people who demonstrated correct or ’good enough’ technique were generally more useful than checklist
scores. Adult studies of enhanced education showed benefit when this metric was used at 2 to 26 weeks’ follow-up (odds ratio (OR)
5.00, 95% confidence interval (CI) 1.83 to 13.65; 258 participants; three studies; 31 per 100 with correct technique in the control
group compared with 69 (95% CI 45 to 86) in the education group; moderate-quality evidence). A similar result was seen in studies
looking at feedback devices at four weeks’ follow-up (OR 4.80, 95% CI 1.87 to 12.33; 97 participants; one study; 51 per 100 with
correct technique in the control group compared with 83 (95% CI 66 to 93) in the feedback group; low-quality evidence). However,
the benefit of multi-media training for adults even immediately after the intervention was uncertain (OR 2.15, 95% CI 0.84 to 5.50;
164 participants; two studies; I² = 49%; 30 per 100 in the control group with correct technique compared with 47 (95% CI 26 to 70)
in the multi-media group; moderate-quality evidence). Evidence tended to be less clear for children, usually because results were based
on fewer and smaller studies.
Some studies did not report exacerbations in a way that allowed meta-analysis; others provided inconclusive results. Inhaler technique
interventions provided some benefit for asthma control and quality of life but generally did not lead to consistent or important clinical
benefits for adults or children. Confidence intervals included no difference or did not reach a threshold that could be considered
clinically important. Responder analyses sometimes showed improvement among more people in the intervention groups, even though
the mean difference between groups was small. We found no evidence about harms.
Authors’ conclusions
Although interventions to improve inhaler technique may work in some circumstances, the variety of interventions and measurement
methods used hampered our ability to perform meta-analyses and led to low to moderate confidence in our findings. Most included
studies did not report important improvement in clinical outcomes. Guidelines consistently recommend that clinicians check regularly
the inhaler technique of their patients; what is not clear is how clinicians can most effectively intervene if they find a patient’s technique
to be inadequate, and whether such interventions will have a discernible impact on clinical outcomes.
P L A I N L A N G U A G E S U M M A R Y
Strategies to help people with asthma use their inhaler correctly
Background to the question
Many asthma drugs are taken by an inhaler, which deposits the drug directly into the lungs. It is important that the inhaler is taken
properly, so the patient gets the most benefit. Taken properly, asthma drugs can improve symptoms and reduce attacks.
Lots of people do not use their devices correctly. This means that the drug is not delivered properly to the lungs, and as a result, asthma
may not be as well controlled as it should be. People also tell us that they can have more than one type of inhaler, so it is confusing to
know what to do.
We wanted to find out whether teaching people with asthma how to use their inhalers works, and whether this leads to better control
of symptoms and fewer attacks. It may seem obvious, but it is important that doctors and nurses know how best to help people with
asthma.
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Study characteristics
We found 29 studies involving 2210 people with asthma. Studies lasted between 2 and 26 weeks. Studies reported inhaler technique
on a range of different checklists.
We grouped studies into three types: studies testing enhanced face-to-face training session(s), studies using multi-media to deliver
inhaler training (e.g. a video, computer app or game) and studies testing devices that give people visual or audio feedback about
technique.
Studies tested different types of training and used different measures to gauge success, meaning that we could not bring data together.
This was particularly true when we tried to assess effects on asthma attacks, adverse events, visits to a healthcare provider and absences
from work or school.
Key results
Both face-to-face and multi-media inhaler training improved inhaler technique in most studies, although results varied depending on
how and when each technique was assessed.
Some studies reported the number of people who had correct or ’good enough’ technique. More people had correct or ’good enough’
technique after face-to-face training and with feedback devices. But the benefit of multi-media training for adults was uncertain.
Interventions that provide inhaler training may bring some benefit for quality of life and asthma control among adults and children,
but results were varied and studies were small.
Children may receive some benefit but results tended to be less clear for children because fewer and smaller studies have included
children as participants.
Quality of the evidence
For studies like these, it is not possible to blind people to their assigned group. This may bias how people behave or respond to
questionnaires, which reduced our confidence in the findings. We were uncertain about other results because studies did not provide
enough data to show clear benefit.
Conclusions
We cannot say for sure what is the best way to help people learn how to use their inhaler properly. It is important that patients understand
how their inhaler works, so they should ask their doctor or nurse for help.
We also use Cochrane Reviews to make suggestions for future research. We suggest that trials should last longer than six months and
should report adherence information. The most useful information reported was the number of people who had ’good enough’ inhaler
technique, so we urge future trials to report this as well.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Enhanced education compared with control/ usual care for people with asthma
Patient or population: adults and children with asthma
Setting: primary and secondary care
Intervention: enhanced educat ion
Comparison: control/ usual care
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
Number of partici-
pants
(studies)
Quality of the evi-
dence
(GRADE)
Comments
Risk with control/ usual care Risk with enhanced
education
Correct inhaler
technique
Follow-up:
2 to 26 weeks
(adults)
12 to 26 weeks (chil-
dren)
Adults 31 per 100 69 per 100
(45 to 86)
OR 5.00 (1.83 to 13.
65)
258
(3 RCTs)
⊕⊕⊕©
M ODERATEa
Addit ional results
f rom technique rat ing
scales could not be
combined (Analysis 1.
2)
Children 49 per 100 55 per 1,00
(40 to 69)
OR 1.29
(0.70 to 2.36)
175
(2 RCTs)
⊕⊕©©
LOWa,b
One study measured
PIF as a marker for
inhaler technique and
showed benef it (Anal-
ysis 2.2; Analysis 2.3)
Asthma control
score
4 to 26 weeks
Adults - Score in the interven-
t ion group was 0.48
SDs higher than in the
control group
(0.29 lower to 1.24
higher)
- 247
(2 RCTs)
⊕©©©
VERY LOWa,b,c
We were not able
to calculate a control
risk, as the outcome
was measured on dif -
ferent scales
Asthma control re-
sponders
8 to 12 weeks
Adults 42 per 100 70 per 100
(52 to 84)
OR 3.18
(1.47 to 6.88)
134
(2 RCTs)
⊕⊕©©
LOWd
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Exacerbations re-
quiring at least OCS
26 weeks
Adults 10 per 100 13 per 100
(5 to 28)
OR 1.32
(0.49 to 3.55)
158
(1 RCT)
⊕⊕©©
LOWa,b
The same study also
re-
ported exacerbat ions
requiring ED/ hospital-
isat ion. Events were
rare and results impre-
cise
Quality of life
26 weeks
Adults - Score in the interven-
t ion group was 0.52
SDs higher than in the
control group
(0.04 lower to 1.09
higher)
- 247
(2 RCTs)
⊕⊕©©
LOWa,c,e
We were not able
to calculate a control
risk as the outcome
was measured on dif -
ferent scales
Other outcomes No results could be analysed for adverse events, unscheduled visits to a healthcare provider or school/ work absences
* The risk in the intervention group (and its 95% conf idence interval) is based on assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%
CI)
CI: conf idence interval; ED: emergency department; OCS: oral cort icosteroids; OR: odds rat io; PIF: peak inspiratory f low; RCT: randomised controlled trial; RR: risk rat io; SDs:
standard deviat ions
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to the est imate of ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of ef fect but may be substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aStudies contribut ing to this outcome were at high risk of bias in several domains (including performance and detect ion bias).
Downgraded once
bWide conf idence intervals including possible harm and benef it of intervent ion. Downgraded once
cHigh level of stat ist ical inconsistency detected. Downgraded once
dThe two small studies contribut ing to this outcome were ident if ied as abstracts only; it is therefore dif f icult to assess
methodological quality. Studies were considered at high or unclear risk of bias in mult iple domains (including select ion,
performance, detect ion and report ing biases). Downgraded twice
eConf idence interval includes no dif ference with random-ef fects model, driven by stat ist ical heterogeneity. Fixed-ef fect
sensit ivity analysis yields more precise result . Not downgraded
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B A C K G R O U N D
Description of the condition
Asthma is one of the most common chronic diseases in the world.
It affects more than 300 million adults and children, and its preva-
lence is rising. By 2025, it is estimated that a further 100 million
peoplemay be affected by asthma. Asthma is thought to be respon-
sible for approximately 1% of the disability-adjusted life-years lost
globally, and for one in 250 deaths, which makes effective treat-
ment an international priority (Masoli 2004). Although previ-
ously asthma was thought to be a disease primarily of high-income
countries, it is now recognised that much of the global asthma
burden affects low- and middle-income countries (Asher 2006).
Asthma is estimated to be the 14th most important disease in the
world in terms of extent and duration of disability (Global Asthma
Network 2014). Asthma is characterised by chronic inflammation
of the airways, leading to symptoms that include cough, wheeze,
chest tightness and shortness of breath, which typically vary over
time. People with asthma may experience a short-term worsening
of symptoms, known as a ‘flare-up’, an ‘attack’ or an ‘exacerbation’,
which may be life-threatening (GINA 2016).
Inhalation therapy is the most effective treatment for almost all
people with asthma (Dekhuijzen 2007). More than 50 years has
passed since the first inhalers for asthma were introduced for rou-
tine clinical use (Crompton 2006a). The major advantage of the
inhaled route is that the drug is delivered directly to the airways,
where it has a rapid onset of action with a minimal dose, thus lim-
iting systemic side effects. Inhalers are also portable and compact,
which makes them suitable for ambulatory therapy (McFadden
1995).
Today, commonly used inhaled therapies include short-acting
beta-agonists (SABAs, e.g. salbutamol); short-acting muscarinic
antagonists (SAMAs, e.g. ipratropium); long-acting beta-ago-
nists (LABAs, e.g. salmeterol); long-acting muscarinic antagonists
(LAMAs, e.g. tiotropium); and inhaled corticosteroids (ICSs, e.g.
beclomethasone) (BNF 2016). These medications can be used
as required to relieve acute symptoms of asthma (e.g. SABAs,
SAMAs) or for daily maintenance to prevent worsening of symp-
toms (i.e. ICS with LABA or LAMA as an add-on) (BTS/SIGN
2014). Sustained use of ICSs reduces airway inflammation, im-
proves symptoms and reduces asthma-related morbidity and mor-
tality (Barnes 2003; Bårnes 2015).
The first inhalation devices for asthma were pressurised metered
dose inhalers (pMDIs), which were introduced in the 1950s; to-
day, many devices are available and different techniques are re-
quired for their proper use (Crompton 2006a; GINA 2016). In-
haler devices can be divided into twomain groups: pMDIs and dry
powder inhalers (DPIs). pMDIs require the patient to co-ordinate
pressing down on the inhaler canister whilst initiating a slow and
deep inhalation, and DPIs require a rapid and forcible inhalation.
Both inhaler types require a full exhalation before use, and breath-
holding is recommended after use (Haughney 2010). For those
who find the co-ordination required to use a pMDI difficult, a
modified ’breath-actuated’ pMDI can be prescribed or an add-on
device can be used with the inhaler, such as a ‘spacer’ or a ‘hold-
ing chamber’. Spacers provide the added advantage of improv-
ing delivery of the drug to the appropriate portion of the airway
while preventing oropharyngeal deposition, which is particularly
important for ICSs (GINA 2016). Some experts recommend that
a spacer device should be used universally for children five years of
age or younger (Sanchis 2013; GINA 2016). The best choice of
inhaler depends on patient factors such as age, co-ordination and
lung function, as well as on patient preference and local availability
and cost (Haughney 2010; GINA 2016).
Description of the intervention
An intervention to improve inhaler technique may take many
forms, but these interventions broadly fall into three categories:
technological adaptations or interventions; education of the
healthcare provider; and education of the patient or caregiver
(Inhaler Error SteeringCommittee 2013). However, in reality, any
given intervention is unlikely to fall neatly into any single category;
for example, a device that provides feedback on inhaler technique
may have the dual effect of providing education to the patient and
healthcare provider. Interventions may promote self-management
by the patient, monitoring by the healthcare provider or both.
They may be delivered face-to-face, in writing or through the use
of visual or technological aids.
Several currently available inhaler ‘training tools’ could fall under
the ‘technological’ umbrella. These devices have various purposes,
which include giving feedback to the patient or healthcare provider
about inhaler technique and allowing the patient to ‘practise’ the
correct technique; helping to identify the best type of inhaler for
that patient; or testing the inhalation capacity and co-ordination
of the patient (Lavorini 2010).
In addition, inhalers themselves may be developed to be easier to
use; of note, the newer DPIs may be associated with better adher-
ence (Roy 2011), which may be a result of ease of use, and breath-
actuated pMDIs should be considered for those who struggle with
co-ordination (Levy 2013). Simple technological devices such as
‘spacers’ may also improve technique and drug delivery for some
patients (McFadden 1995). However, the literature does not sug-
gest that one type of inhaler is consistently associated with a better
technique than any other (van Beerendonk 1998). A 2001 Health
Technology Assessment report concluded that no consistent ad-
vantage is offered by one type of inhaler over another after proper
training, and so the cheapest option should be selected in most
cases (Brocklebank 2001). More recently, a ’real-world’ cost-ef-
fectiveness analysis based on routine observational data compared
outcomes for patients initiated on ICS via a pMDI, a breath-actu-
ated inhaler pMDI or a DPI. Findings suggest that the real-world
effectiveness of ICS inhalers varies (which may be attributed in
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part to technique) and that both subsequent healthcare usage costs
and the cost of the inhaler should be taken into account when
prescribing (Kemp 2010).
Education of both healthcare professionals and patients about cor-
rect techniquemay be delivered in several ways.Multi-media train-
ing tools may comprise Internet-based or DVD video clips that
demonstrate correct inhaler use, as well as interactive components
such as games or quizzes (Navarre 2007; Lavorini 2010; Poureslami
2012). Indeed, it has been demonstrated that education delivered
via the Internet can be as effective, at least in the short term, as
face-to-face training for healthcare professionals (Erikson 2003;
Toumas 2009).
Face-to-face education or coaching is another commonly used
strategy for improving inhaler technique. This may be done as
part of a comprehensive asthma management package and can
be delivered to, or by, a variety of healthcare professionals, in-
cluding nurses, pharmacists and physicians (Verver 1996; Basheti
2005; Basheti 2008; Armour 2013). Studies have shown that even
brief interventions can substantially improve medical profession-
als’ knowledge about correct technique (Basheti 2009; Kim 2009).
Trials of telephone interventions aimed at patients have yielded
mixed results (Bynum 2001; Nelson 2011).
How the intervention might work
The breadth of interventions available to improve inhaler tech-
nique means that no single mechanism has been identified by
which clinical outcomes might benefit. Some technological in-
terventions may allow optimisation of the choice of inhaler for
a patient by characterising the patient’s breathing pattern, thus
improving technique, or by allowing a patient to hone his or her
technique at home or with the assistance of a healthcare profes-
sional (Lavorini 2010). Attempts to minimise the number of dif-
ferent types of inhalers prescribed for one patientmay also improve
technique; studies suggest that both adults and children who are
prescribed more than one type of inhaler, especially a mixture of
pMDIs and DPIs, are more likely to make inhaler errors (van der
Palen 1999; Alotabi 2011).
Other interventions may ensure that a patient is following the
correct sequence of steps for proper use; physical demonstration
appears superior to verbal or written instructions alone (Basheti
2005; Bosnic-Anticevich 2010), and a multi-media presentation
may be superior to written information alone (Savage 2003). This
suggests that being able to watch and copy as the correct technique
is demonstrated in person or via a video clip or the Internet is an
important requirement for the intervention in many cases.
Children present a unique challenge, and evidence suggests that
even after training, their inhaler technique may remain inade-
quate for effective drug delivery (Kamps 2000). Some studies
suggest that repeated training with reinforcement is important
(Deerojanawong 2009), that audiovisual training alone is insuf-
ficient and that children show the greatest improvement when
they receive individual training with follow-up at home (Agertoft
1998).
Knowledge of how a technique is assessed and recorded is impor-
tant for determining whether or not an intervention has worked.
As anticipated, we found that not all studies used a validated mea-
surement instrument (Rootmensen 2010). We considered how
each trial that contributed to this Cochrane Review assessed tech-
nique and how this impacted our confidence in this outcome.
Why it is important to do this review
As many as 70% to 80% of people with asthma are unable to
use their inhaler device correctly (GINA 2016); poor technique
has been associated with age, sex, educational level and emotional
problems (Rootmensen 2010). Studies suggest that up to 67% of
clinicians cannot describe the steps involved or cannot demon-
strate correct inhaler use. Furthermore, of the approximate USD
50 billion spent annually on inhalers (for all respiratory condi-
tions) in the USA, USD 7 to 15 billion is wasted owing to im-
proper use (Fink 2005). Mistakes in inhaler use have been as-
sociated with poor clinical outcomes in asthma, including more
frequent emergency department (ED) visits; hospitalisations; pre-
scriptions of oral steroids and antimicrobials; and poorer asthma
control as assessed by the Asthma Control Questionnaire (ACQ),
the Asthma Instability Score (AIS) and the Asthma Therapy As-
sessment Questionnaire (ATAQ) (Giraud 2001; Melani 2011;
Al-Jahdali 2013; Westerik 2016). A similar association is seen
in children (Capanoglu 2015). Evidence suggests that even after
a successful intervention, many patients revert to incorrect use
within a short time (Price 2002; Crompton 2006b).
International and national guidelines highlight that assessment of
inhaler technique is an essential component of asthma care, es-
pecially for patients with inadequate control (BTS/SIGN 2014;
GINA 2016). Recently, the Aerosol Drug Management Improve-
mentTeam (ADMIT) published a series of papers that focus on the
need to improve inhalation technique in Europe (ADMIT 2016).
In summary, the ADMIT reports suggest that specific education
for patients and clinicians on correct technique for inhaler use is
needed and should be repeated frequently; devices that provide
‘feedback’ about appropriate technique are useful; information
about the correct technique for each device should be easily acces-
sible; and standardised prescribing throughout Europe is prefer-
able (Crompton 2006b; Dekhuijzen 2007). The Global Allergy
and Asthma European Network (GA²LEN) initiative, which fo-
cusses on problematic severe asthma in children, calls for repeated
checking of an individual’s inhaler technique (Hedlin 2010). This
inevitably raises the question of what is the most effective way to
correct and improve improper technique.
Lewis 2016 developed a model to estimate the impact of poor in-
halation technique on the economic burden of asthma and chronic
obstructive pulmonary disease (COPD) in three European coun-
tries (Spain, Sweden and the United Kingdom). Study authors
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attributed 2.2% to 2.7% of direct asthma and COPD costs to
poor inhalation technique, totaling 105 million euros across the
three countries. Inclusion of lost productivity costs in additional
analyses revealed that the annual expenditure was increased to 3.3
billion euros in the UK and 6.4 billion euros across all three coun-
tries. These figures further highlight the need for effective inter-
ventions to improve inhaler technique.
Although the literature provides compelling evidence of the need
for good inhaler technique in maintaining asthma control, the
most effective ways to improve inhaler technique and thus improve
clinical outcomes remain unclear. This Cochrane Review exam-
ined the evidence for this question for both adults and children.
O B J E C T I V E S
To assess the impact of interventions to improve inhaler technique
on clinical outcomes and safety in adults and childrenwith asthma.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included parallel and cluster-randomised controlled trials
(RCTs) of any duration conducted in any setting. If we identified
cross-over trials, we included only data from the first part of the
study because of the potential for carry-over effects from the in-
tervention.
We included studies reported as full-text articles, published as
abstracts only and described in unpublished data.
Types of participants
We included both adults and children with asthma, diagnosed ac-
cording to national or international guidelines or by a healthcare
professional. We excluded participants with other respiratory co-
morbidities, including COPD and bronchiectasis. If we identified
a study in which only a subset of participants had asthma, we in-
cluded these participants if we were able to obtain disaggregated
data.
We intended to analyse studies aimed solely at children (younger
than 12 years) separately from those aimed at adults and adoles-
cents (12 years of age and older). If within each of these compar-
isons we found trials focused on a more narrow age range (e.g.
children younger than five years), we explored this potential source
of heterogeneity. If a study recruited both adults and children and
did not provide disaggregated data, we were guided by the average
age of participants to determine in which comparison we should
include the study.
Types of interventions
We included studies that compared an intervention primarily
aimed at improving inhaler technique versus any of the following.
1. Usual care/No additional intervention.
2. An alternative intervention that did not primarily aim to
improve inhaler technique (e.g. asthma education only vs asthma
education plus an inhaler technique demonstration).
3. An alternative intervention of a different type or intensity,
also aimed at improving inhaler technique (e.g. written
instructions only vs written instructions plus physical
demonstration).
It is likely that the effect of the intervention will be systematically
different depending on which of these three types of comparison
groups each study used, so we meta-analysed results separately un-
less we had a justification for pooling data (i.e. if treatments, par-
ticipants and the underlying clinical question were similar enough
for pooling to make sense).
Trial interventions may be delivered to healthcare professionals
(e.g. pharmacists, healthcare assistants, nurses, physicians) or di-
rectly to patients or their parents/caregivers. Interventions may
involve education delivered face-to-face or remotely, and may in-
clude written, verbal or multi-media methods of delivery. Inter-
ventions may also involve a device or a piece of technology de-
signed to improve inhaler technique.
’Usual care’ comprises the treatment that a patient with asthma
in this setting would normally receive according to local or na-
tional guidelines, or according to the judgement of their healthcare
provider. This may include routine advice about inhaler technique
but not about the specific intervention that is being studied.
Types of outcome measures
Primary outcomes
1. Inhaler technique (as assessed/rated by triallist; change from
baseline scores preferred if available)
2. Asthma control (preferably measured on a validated scale,
e.g. Asthma Control Questionnaire (ACQ))
3. Asthma exacerbations requiring at least oral corticosteroids
(OCSs)
Secondary outcomes
1. Quality of life (preferably measured on a validated scale,
e.g. Asthma Quality of Life Questionnaire (AQLQ))
2. Adverse events (including local drug side effects, which can
be associated with improper inhaler technique)
3. Unscheduled visits to healthcare provider (e.g. emergency
department (ED), primary care)
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4. Absenteeism from work or school
Reporting of one or more of the outcomes listed here within a
study was not an inclusion criterion for the review.
We chose these outcomes to reflect the main aim of the inter-
vention (improved inhaler technique) but also patient-important
clinical outcomes, such as exacerbations and quality of life. Ad-
verse events may be associated with improper inhaler use (e.g.
oropharyngeal deposition of ICS) andmay decrease post interven-
tion. Alternatively, some participants may have noted an increase
in medication side effects as they were not receiving a therapeu-
tic dose of their inhaler previously. We did not anticipate many
serious adverse events linked to the intervention and so chose to
capture all adverse events.
Search methods for identification of studies
Electronic searches
We identified studies from the Cochrane Airways Trials Register,
which is maintained by the Information Specialist for the Group.
The Cochrane Airways Trials Register includes studies identified
from several sources.
1. Monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL), through the Cochrane Register
of Studies Online (crso.cochrane.org).
2. Weekly searches of MEDLINE Ovid SP 1946 to date.
3. Weekly searches of Embase Ovid SP 1974 to date.
4. Monthly searches of PsycINFO Ovid SP.
5. Monthly searches of the Cumulative Index to Nursing and
Allied Health Literature (CINAHL) EBSCO.
6. Monthly searches of Allied and Complementary Medicine
(AMED) EBSCO.
7. Handsearches of the proceedings of major respiratory
conferences.
Studies included in the Trials Register are identified through search
strategies based on the scope of Cochrane Airways. We have pro-
vided details of these strategies, as well as a list of handsearched
conference proceedings, in Appendix 1. See Appendix 2 for search
terms used to identify studies for this review.
We searched the following trials registries.
1. US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov (www.clinicaltrials.gov).
2. World Health Organization International Clinical Trials
Registry Platform (apps.who.int/trialsearch).
We searched the Cochrane Airways Trials Register and additional
sources from inception to the present, with no restriction on lan-
guage of publication. We conducted the most recent search on 23
November 2016.
Searching other resources
We checked the reference lists of all primary studies and review
articles for additional references. We searched relevant manufac-
turers’ websites for trial information.
On 24 November 2016, we searched for errata or retractions
from included studies published in full text on PubMed (
www.ncbi.nlm.nih.gov/pubmed).
Data collection and analysis
Selection of studies
Two review authors (KK and RN or AM) screened titles and ab-
stracts independently of all studies identified for potential inclu-
sion as a result of the search, and coded them as ’retrieve’ (eligible
or potentially eligible/unclear) or ’do not retrieve’. We retrieved
full-text study reports/publications; two review authors (RN and
KK) independently screened the full-text reports, identified stud-
ies for inclusion and identified and recorded reasons for exclusion
of ineligible studies. We resolved disagreements through discus-
sion, or, if required, we consulted a third review author. We iden-
tified and excluded duplicates and collated multiple reports of the
same study, so that each study, rather than each report, was the
unit of interest in the review. We recorded the selection process
in sufficient detail to complete a Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) flow diagram
and a Characteristics of excluded studies table (Moher 2009).
Data extraction and management
We piloted a data collection form on at least one study included
in the review and used it to document study characteristics and
outcome data. One review author (RN, KK or AM) extracted the
following study characteristics from the included studies.
1. Methods: study design, total duration of study, details of
any ’run-in’ period, number of study centres and locations, study
settings, withdrawals, dates of study.
2. Participants: N, mean age, age range, gender, severity of
condition, diagnostic criteria, baseline lung function, smoking
history, inclusion criteria, exclusion criteria.
3. Interventions: intervention, comparison, allowed
medications and concomitant interventions, excluded
medications and interventions.
4. Outcomes: primary and secondary outcomes specified and
collected, time points reported.
5. Notes: funding for trial, notable conflicts of interest of trial
authors.
Two review authors (RN and KK or AM) independently ex-
tracted outcome data from the included studies. We noted in the
Characteristics of included studies table if the included trials did
not report outcome data in a useable way. We resolved disagree-
ments by reaching consensus or by consulting a third review au-
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thor. One review author (RN) transferred data into Review Man-
ager (RevMan) (RevMan 2014). We double-checked that the re-
view author had entered data correctly by comparing data pre-
sented in the systematic review versus the study reports. A second
review author (KK or RN) spot-checked study characteristics for
accuracy against the trial report.
Assessment of risk of bias in included studies
Two review authors (RN and KK or AM) independently assessed
the risk of bias of each included study using the criteria outlined
in the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011). We resolved disagreements by discussion or by
consultation with a third review author. We assessed risk of bias
according to the following domains.
1. Random sequence generation.
2. Allocation concealment.
3. Blinding of participants and personnel.
4. Blinding of outcome assessment.
5. Incomplete outcome data.
6. Selective outcome reporting.
7. Other bias.
We graded each potential source of bias as high, low or unclear
and provided a quote from the study report and a justification
for our judgement in the ’Risk of bias’ table. We summarised
’Risk of bias’ judgements across different studies for each of the
domains listed.We considered blinding separately for different key
outcomes when necessary (e.g. for unblinded outcome assessment,
risk of bias for all-cause mortality may be very different from that
determined for a patient-reported pain scale). When information
on risk of bias was related to unpublished data or correspondence
with a triallist, we noted this in the ’Risk of bias’ table.
When we considered treatment effects, we took into account the
risk of bias for studies that contributed to those outcomes.
Assessment of bias in conducting the systematic
review
We conducted the review according to the published protocol and
reported deviations from it in the Differences between protocol
and review section of the systematic review.
Measures of treatment effect
We analysed dichotomous data usingMantel-Haenzsel odds ratios
(ORs) with a random-effects model and 95% confidence intervals
(CIs). If we had encountered outcomes with very rare events, we
planned to use PetoORs. If the included trials had reported data as
rates or time-to-event (e.g. exacerbations), we planned to analyse
these as time-to-event or rate ratios. We planned to transform
reported rate ratios into log rate ratios and to analyse them using
a random-effects model and generic inverse variance (GIV) in
RevMan (RevMan 2014). We entered data presented as a scale
with a consistent direction of effect.
We analysed continuous outcomes (e.g. ACQ, AQLQ) as mean
difference (MD) or standardised mean difference (SMD) values
using a random-effects model and 95%CIs.We used change from
baseline scores when available.
We undertook meta-analyses only where this was meaningful i.e.
if the treatments, participants and the underlying clinical question
were similar enough for pooling to make sense.
We narratively described skewed data reported as medians and
interquartile ranges.
When a single trial reported multiple trial arms, we included only
the relevant trial arms. If we combined two comparisons (e.g.
intervention A vs usual care and intervention B vs usual care) in
one meta-analysis, we halved the control group to avoid double-
counting.
Unit of analysis issues
We analysed dichotomous data by using participants (rather than
events) as the unit of analysis. However, if the included trials had
reported exacerbations as rate ratios, we planned to analyse them
on this basis. We meta-analysed data from cluster RCTs only if we
could adjust available data to account for clustering.
Dealing with missing data
We contacted investigators or study sponsors to verify key study
characteristics and to obtain missing numerical outcome data
when possible (e.g. when we identified a study as an abstract only).
When this was not possible, and we thought that the missing
data introduced serious bias, we took this into consideration in
the Grading of Recommendations Assessment, Development and
Evaluation (GRADE) rating for affected outcomes.
Assessment of heterogeneity
We used the I² statistic to measure heterogeneity amongst the tri-
als in each analysis. If we identified substantial heterogeneity, we
reported this and explored possible causes by performing prespec-
ified subgroup analysis.
Assessment of reporting biases
When we were able to pool more than 10 trials, we created and
examined a funnel plot to explore possible small study and publi-
cation biases.
Data synthesis
We used a random-effects model and performed a sensitivity anal-
ysis with a fixed-effect model.
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’Summary of findings’ table
We created a ’Summary of findings’ table and included the fol-
lowing outcomes: inhaler technique; asthma control; asthma ex-
acerbations; quality of life; adverse events; unscheduled visit to
healthcare provider; and absenteeism from work or school.
We used the five GRADE considerations (study limitations, con-
sistency of effect, imprecision, indirectness and publication bias)
to assess the quality of a body of evidence as it related to studies that
contributed data to the meta-analyses for prespecified outcomes.
We used methods and recommendations described in Section 8.5
and Chapter 12 of theCochraneHandbook for Systematic Reviews of
Interventions (Higgins 2011), and we used GRADEpro Guideline
Development Tool (GDT) software (GRADEpro GDT). We jus-
tified all decisions to downgrade or upgrade the quality of the ev-
idence by using footnotes. We made comments to aid the reader’s
understanding of the review when necessary.
Subgroup analysis and investigation of heterogeneity
We planned the following subgroup analyses.
1. To whom the intervention is delivered: healthcare provider
versus patient/caregiver.
2. Duration of intervention: one-off session versus repeated
sessions.
We did not pool studies that included childrenwith studies that in-
cluded adults. If within each of these two populationswe found tri-
als that focused on a more narrow age range (e.g. children younger
than five years of age), we planned to explore this potential source
of heterogeneity.
We suspected that interventions would differ from one another
in various ways (e.g. inhaler type, physical demonstration vs no
demonstration, remote vs face-to-face), which may make explo-
ration through multiple formal subgroup analyses misleading. In-
stead we summarised intervention characteristics in additional ta-
bles (Table 1; Table 2; Table 3).
We used the following outcomes in subgroup analyses.
1. Inhaler technique.
2. Asthma control.
3. Asthma exacerbations requiring at least OCS.
We used the formal test for subgroup interactions in RevMan
(RevMan 2014). When we found insufficient studies to conduct
these analyses formally, we displayed in a table summary informa-
tion regarding each of these variables.
Sensitivity analysis
We planned the following sensitivity analyses.
1. Exclusion of unpublished data.
2. Exclusion of studies considered at high risk of selection bias.
3. Exclusion of studies that did not use a validated tool to
assess inhaler technique (from the inhaler technique outcome).
R E S U L T S
Description of studies
Results of the search
We identified a total of 803 unique potentially relevant records,
including 718 records from the main electronic database search
and 85 additional records from the clinical trial registries Clini-
calTrials.gov (n = 76) and the World Health Organization Inter-
national Clinical Trial Registry Platrform (WHO ICTRP; n = 9).
After removing duplicates, we reviewed 791 records and excluded
694 by looking at titles and abstracts alone. We reviewed full-text
articles for the remaining 97 records. Fifty-seven records related
to 46 studies did not meet the inclusion criteria, and we excluded
them (with reasons - see Figure 1). We deemed 40 records related
to 29 studies eligible for this review.
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Figure 1. Study flow diagram.
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Included studies
Twenty-nine studies, evaluating 2210 participants (children and
adults), met the inclusion criteria for this review (Self 1983; Lirsac
1991; Donateo 1996; Turgeon 1996; Agertoft 1998; Rydman
1999; Bynum 2001; Boone 2002; Savage 2003; Basheti 2005;
Goodyer 2006; Al-Showair 2007; Basheti 2008; Mehuys 2008;
Tarsin 2008; Acosta 2009; Nahafizadeh 2010; Ozkaya 2010;
Fernandes 2011; Schultz 2012; Ammari 2013; Vitari 2013;
Arthurs 2014; Rahmati 2014; Shah 2014; Toumas-Shehata 2014;
Ammari 2015; Ammari 2015a; Carpenter 2015). Detailed de-
scriptions of these studies and risk of bias details can be found in
the Characteristics of included studies table.
All included studies were parallel RCTs. The study population in
each study ranged from 21 to 201 participants, and the median
number of participants was 72. Eleven of the included studies took
place in Europe (six in the UK and one in each of the following
countries: Belgium; Denmark; France; Ireland; and Italy), seven
in USA, four in Australia, three in Asia and one in Africa, and
three of the included studies did not report the country of origin.
Fourteen studies were hospital based: 11 were conducted in out-
patient clinics (Self 1983; Turgeon 1996; Agertoft 1998; Rydman
1999; Al-Showair 2007;Nahafizadeh 2010;Ozkaya 2010; Schultz
2012; Ammari 2013; Rahmati 2014; Ammari 2015), one took
place in a hospital ward (Arthurs 2014) and two did not pro-
vide details (Fernandes 2011; Shah 2014). Five studies were con-
ducted in primary care facilities (Bynum 2001; Boone 2002;
Savage 2003; Goodyer 2006; Carpenter 2015), four took place
in community pharmacies (Basheti 2005; Basheti 2008; Mehuys
2008; Toumas-Shehata 2014), one was carried out in a compre-
hensive lung centre (Vitari 2013) and five did not reveal the set-
ting in which they were conducted (Lirsac 1991; Donateo 1996;
Tarsin 2008; Acosta 2009; Ammari 2015a).
Population characteristics and inclusion criteria
Seven studies included only children (Agertoft 1998; Boone
2002; Ozkaya 2010; Schultz 2012; Arthurs 2014; Ammari 2015;
Ammari 2015a) and 12 only adults (Self 1983; Donateo 1996;
Rydman 1999; Goodyer 2006; Al-Showair 2007; Basheti 2008;
Mehuys 2008; Acosta 2009; Nahafizadeh 2010; Fernandes 2011;
Rahmati 2014; Toumas-Shehata 2014). Two of the children’s stud-
ies also included adolescents (Turgeon 1996;Carpenter 2015), and
three included adults and adolescents (Lirsac 1991; Savage 2003;
Basheti 2005); these studies were classified as children’s and adults’
studies, respectively. One study included only adolescents aged 12
to 17 years (Bynum 2001), and one included both children and
adults (Ammari 2013). Finally, three studies did not report the
age range of participants (Tarsin 2008; Vitari 2013; Shah 2014);
none of these three studies contributed to a meta-analysis. The
mean age of the overall population was 28.52 years. The mean
ages of adult and children populations were 44.42 and 6.97 years,
respectively.
All included studies required a diagnosis of asthma. Other fre-
quently used inclusion criteria were age ranges, type of inhaler
used, use of a spacer, absence of recent exacerbations, asthma con-
trol, non-acceptable inhaler technique and specific components
of the technique. Two studies did not report inclusion criteria
(Nahafizadeh 2010; Shah 2014).
Interventions and comparisons
Interventions assessed in the included trials can be categorised into
three broad groups:
1. Enhanced inhaler technique education, delivered by a
trained individual to a healthcare professional (who in turn
educated the patient) or directly to the patient (Table 1). Twelve
studies implemented face-to-face verbal training with or without
demonstration of appropriate inhaler technique (Self 1983;
Turgeon 1996; Agertoft 1998; Rydman 1999; Bynum 2001;
Basheti 2005; Basheti 2008; Mehuys 2008; Nahafizadeh 2010;
Ozkaya 2010; Fernandes 2011; Rahmati 2014).
2. Multi-media training (Table 2). Four studies used
educational computer applications or games (Boone 2002;
Savage 2003; Goodyer 2006; Shah 2014). Five studies used
instructional videos with or without written information (Self
1983; Lirsac 1991; Acosta 2009; Arthurs 2014; Carpenter 2015).
3. Training devices providing visual or audio feedback
regarding the appropriateness of breathing manoeuvres (Table 3).
Patients used these devices for different periods to maintain an
acceptable inhaler technique. Three of the included studies used
a two-tone trainer - a training device that looks like an MDI and
provides different audio feedback for acceptable versus non-
acceptable inspiratory flow rates (Al-Showair 2007; Tarsin 2008;
Ammari 2013). Trainhaler also provided audible feedback for
appropriate breathing manoeuvres with an MDI (Ammari
2015a). AeroChamber Plus with Flow-Vu (Ammari 2015), a
portable hand-held spirometer, was used to assess breathing
manoeuvres associated with the use of different inhaler devices
(Toumas-Shehata 2014), and In-Check (Vitari 2013) provided
visual feedback for appropriateness of breathing manoeuvres
with MDI, DPI and different types of inhalers, respectively.
Finally Funhaler, a spacer device, provides combined visual and
audible feedback for correct inhaler technique with an MDI
inhaler (Schultz 2012).
One study used spacer devices to simplify inhalation technique by
reducing the need for co-ordination of actuation and inhalation
and increasing deposition in lower airways (Donateo 1996). An-
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other study used a spacer device to implement a complex inter-
vention, which included educational sessions and use of a spacer
versus an educational session alone or no intervention (Rahmati
2014).
Comparators used varied among included studies; some used stan-
dard inhaler technique verbal instruction; others used written in-
structions, sham video instructions or no instructions.
Excluded studies
Title and abstract screening of articles identified through our
systematic searches revealed 97 potentially relevant records.
After reviewing the full texts of these articles, we excluded
57 records describing 46 studies, as described in Figure 1.
We classified six studies, described in seven records, as on-
going (ACTRN12610000159055; JPRN-UMIN000006739;
NCT02203266;
NCT02283008; NCT02611531; NCT01529697) and two stud-
ies as awaiting classification because we did not find adequate de-
tails to confirm whether they met the review’s inclusion criteria
(NCT02062463; Westhus 1998). Finally, we excluded 38 stud-
ies (48 citations) because they did not meet the inclusion cri-
teria. Of these, seven studies used the wrong study design for
the review (WIlliams 1983; Epstein 2001; Andres Jacome 2003;
Schacer 2005; Lee 2010; SandosDde 2010; Azouz 2015), 10 stud-
ies focused on a wrong study population for the review (McElnay
1989; Verver 1996; Compton 2000; Hesselink 2004; Basheti
2005a; Bosnic-Anticevich 2010; Jolly 2012;NCT01456494; Jolly
2015; NCT01426581) and 21 studies did not assess the interven-
tion of interest for this review (NCT01641211; NCT02046759;
NCT02307669; NCT02363192; NCT02715219; Eriksson
1980; Hodges 1981; Pedersen 1983; Rachelefsky 1986; Reiser
1986; Yoon 1993; Wong 1995; Mulloy 1996; Tuazon 2002;
Kritikos 2007; Horner 2008; Garcia-Cardenas 2013; Fornell
2014; Eakin 2015; Grover 2016; Poureslami 2016).
Risk of bias in included studies
We have presented in Figure 2 an overview of risk of bias in the
included studies. We have also provided a summary of possible
bias related to each domain. We have given details on the rationale
for each judgement of each study’s risk in the risk of bias table for
each study (see the Characteristics of included studies tables).
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Most included studies provided very limited information regard-
ing the two selection bias domains. We deemed 12 of the included
studies to be at low risk of bias for random sequence generation
(Lirsac 1991; Turgeon 1996; Bynum 2001; Savage 2003; Goodyer
2006; Basheti 2008; Mehuys 2008; Schultz 2012; Ammari 2013;
Rahmati 2014; Ammari 2015; Carpenter 2015) and only three to
be at low risk for allocation concealment (Lirsac 1991; Mehuys
2008; Carpenter 2015). We deemed one study to be at high risk
for allocation concealment bias (Shah 2014), and we rated risk of
bias of remaining studies in each selection bias domain as unclear.
Blinding
Blinding of participants and personnel to group allocation is chal-
lenging because of the nature of the interventions and compar-
isons; this posed the most significant risk of bias for the evidence
in this review. Only one trial reported blinding of participants and
personnel (Boone 2002), and we assessed this study as low risk.
We judged another trial involving young children, which used a
relatively objective measure (lung function), to be at low risk de-
spite lack of blinding (Agertoft 1998). One trial did not report on
blinding of participants and personnel; as a result, we rated risk of
performance bias for this study as unclear (Fernandes 2011). We
deemed all remaining studies as having high risk of performance
bias because they were not blinded.
We deemed risk of detection bias to be low in only seven trials
(Donateo 1996; Turgeon 1996; Agertoft 1998; Rydman 1999;
Savage 2003;Goodyer 2006; Acosta 2009). In the remaining trials,
risk of detection bias was high, with the exception of three trials,
which we deemed to have unclear risk (Self 1983; Vitari 2013;
Shah 2014).
Incomplete outcome data
Sixteen of the included studies had low and balanced attrition
across study arms; we deemed these studies to have low risk of bias
for incomplete outcome data (Self 1983; Lirsac 1991; Donateo
1996; Agertoft 1998; Rydman 1999; Savage 2003; Basheti 2005;
Goodyer 2006; Al-Showair 2007; Nahafizadeh 2010; Ammari
2013; Vitari 2013; Rahmati 2014; Toumas-Shehata 2014;
Ammari 2015; Carpenter 2015). We rated risk of attrition bias
as high in five of the included trials with high or unequal drop-
out (Turgeon 1996; Bynum 2001; Basheti 2008; Mehuys 2008;
Schultz 2012) and as unclear in the remaining studies.
Selective reporting
We rated only one study as having low risk of reporting bias (
Carpenter 2015) and found 11 of the remaining trials to be at high
risk of reporting bias (Lirsac 1991; Turgeon 1996; Basheti 2005;
Tarsin 2008; Acosta 2009; Ozkaya 2010; Fernandes 2011; Vitari
2013; Arthurs 2014; Shah 2014; Ammari 2015a). Finally, we were
not able to assign a clear risk of bias to the remaining trials, usually
because we could not identify a prospective trial registration or a
prepublished protocol.
Other potential sources of bias
We did not identify any other potential sources of bias in the
included studies.
Effects of interventions
See: Summary of findings for the main comparison Enhanced
education compared with control versus usual care for people with
asthma; Summary of findings 2 Multimedia training compared
with control versus usual care for people with asthma; Summary
of findings 3 Feedback device compared with control versus usual
care for people with asthma
Structure of the analysis
After examining the data, we found that included studies fell into
three main comparisons. As planned, we analysed studies that
recruited children (mean age < 12 years) separately from those that
recruited adolescents and adults (mean age ≥ 12 years), resulting
in six main comparisons.
1. Comparisons 1 (adults) and 2 (children):enhanced inhaler
technique education versus control or usual care. Investigators
delivered education directly to the participant or to a healthcare
professional (e.g. a pharmacist) and the intervention could be a
’one-off ’ intervention or could be repeated one or more times.
We explored these differences within comparisons in our
prespecified subgroup analyses.
2. Comparisons 3 (adults) and 4 (children):multi-media
training versus control or usual care. This included videos and
computer programmes, which, in the case of our included
studies, investigators always delivered directly to the participant.
Some studies used a one-off delivery of the intervention, and in
others, participants had ongoing access to the resource. We
planned to explore this in our prespecified subgroup analysis, but
for all studies in adults, this was a one-off intervention, and for
all studies in children, participants had ongoing access at home.
3. Comparisons 5 (adults) and 6 (children):feedback device
versus control or usual care. Investigators provided devices that
gave audio or visual (or both) feedback to the participant on
inhaler technique. All but one of the studies that we included in
this comparison allowed participants to use the device at home
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between study visits; thus this prespecified subgroup analysis was
not possible.
In the following section, we present results separately for each
comparison, with any relevant subgroup or sensitivity analyses
described at the end of each comparison section.
Comparisons 1 and 2: enhanced inhaler technique
education versus control or usual care
Nine studies in adults (Self 1983; Rydman 1999; Bynum 2001;
Basheti 2005; Basheti 2008; Mehuys 2008; Nahafizadeh 2010;
Fernandes 2011; Rahmati 2014) and three studies in children
(Turgeon 1996; Agertoft 1998; Ozkaya 2010) contributed to this
comparison.
Inhaler technique
Contributing studies measured this in several ways and at different
time points. Investigators most commonly used a checklist, which
resulted in a score reflecting the number of steps performed cor-
rectly, but these results were too varied to pool. Another method
was to dichotomise participants into those with and those with-
out ’satisfactory’ or ’correct’ inhaler technique at follow-up. Study
authors usually defined satisfactory or correct as performing all
critical steps correctly.
Among adults, more people in the intervention group than in the
control group had correct technique at follow-up, with moderate
to substantial heterogeneity (Analysis 1.1; OR 5.00, 95% CI 1.83
to 13.65; 258 participants; three studies; I² = 57%; moderate-
quality evidence). This equates to 31 out of 100 people having
correct technique at 2- to 26-week follow-up in the control group
compared with 69 out of 100 (95% CI 45 to 86) in the active
intervention group (Figure 3).
Figure 3. In the control group, 31 out of 100 people had correct inhaler technique after 2 to 26 weeks,
compared with 69 (95% CI 45 to 86) out of 100 in the active treatment group.
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Weconsidered combining checklist scales using standardisedmean
difference, but statistical heterogeneity was extremely high and
data from individual trials were often heavily skewed. Instead, we
have presented effect estimates from the individual studies in data
tables. Among adults, when investigators measured performance
immediately after delivery of the intervention by using a check-
list, they found that inhaler technique education improved inhaler
technique over control in most studies (Analysis 1.2). However,
these studies have widely different effect estimates and varied pre-
cision and provided a similar picture at follow-up of 2 to 26 weeks
(also shown in Analysis 1.2).
Among children, two studies dichotomised participants to those
with and without correct technique at follow-up (between 12 and
26 weeks) and found no significant differences between groups,
with confidence intervals including both potential harm and ben-
efit of the intervention (Analysis 2.1; OR 1.29, 95% CI 0.70 to
2.36; 175participants; two studies; I² = 0%; low-quality evidence).
One small study measured peak inspiratory flow rate immediately
after the intervention to assess inhaler technique. It should be
noted that participants in this study were young children (three to
five years of age) who were being trained in Turbuhaler use, which
requires a rapid, forceful inhalation; thus the applicability of this
finding to other populations may be limited. Results showed ben-
efit in favour of the educational intervention (Analysis 2.2; MD
10.00, 95% CI 2.16 to 17.84). The same study measured this
again at two-week follow-up and reported that benefit was main-
tained (Analysis 2.3; MD 7.60, 95% CI 1.43 to 13.77).
Asthma control
Among adults, researchers measured asthma control using the
ACT - “perceived asthma control” - on a 0 to 55 scale and di-
chotomised results into complete control versus incomplete con-
trol on the ACT. None of the included studies of children in this
comparison reported asthma control.
We combined ACT and perceived asthma control scores, both
measured at 26 weeks, using SMD. Analysis revealed benefit in
favour of the educational intervention but with a lower confidence
interval, including no difference and high statistical heterogeneity
(Analysis 1.3; SMD 0.48, 95%CI -0.29 to 1.24; 247 participants;
two studies; I² = 88%; very low-quality evidence). Two small stud-
ies reported “complete control” and meta-analysis favoured the
educational intervention (Analysis 1.4; OR 3.18, 95% CI 1.47
to 6.88; 134 participants; two studies; I² = 0%; low-quality evi-
dence).
Exacerbations
Only one study in adults reported asthma exacerbations at 26
weeks (Mehuys 2008). A similar number of participants in each
group experienced an exacerbation requiring at least OCS treat-
ment (10 vs 8), and although more participants in the control
group experienced an exacerbation requiring an ED visit or hos-
pital admission (1 vs 5), events were too infrequent to allow inves-
tigators to draw a conclusion. We considered the evidence of low
quality.
Quality of life
Again, for this comparison, only studies involving adults reported
quality of life, and both reported this outcome at 26 weeks. One
study used asthma-related quality of life (AQOL) and the other
used the AQLQ. We combined both scales using SMD; although
results favoured the educational intervention, the lower confidence
interval included no difference and heterogeneity was substantial
(Analysis 1.7; SMD 0.52, 95%CI -0.04 to 1.09; 247 participants;
two studies; I2 = 78%; low-quality evidence).
Adverse events
One study involving 97 adults (Basheti 2008) reported that no
“clinically important adverse events” occurred during the 26-week
follow-up.
Investigators reported the following outcomes in a way that did
not allow meta-analysis by any of the studies in this comparison:
unscheduled visits to healthcare provider; and absenteeism from
work or school.
Subgroup analyses
To whom the intervention was delivered: patient versus
healthcare professional
Wewere unable to perform this subgroup analysis for inhaler tech-
nique score, as we chose not to perform a meta-analysis owing to
substantial heterogeneity.
We were able to perform a formal test of subgroup differences
for dichotomised inhaler technique and asthma control in adults
(Analysis 1.8; Analysis 1.9); for both analyses, the subgroup analy-
sis suggests that it may be more effective to deliver the educational
intervention to pharmacists rather than directly to patients. How-
ever, very few studies contributed to these analyses, and baseline
ACT and AQLQ inMehuys 2008 (a study in which the interven-
tion was delivered to participants) was high, perhaps limiting the
scope for improved control among these participants. Therefore,
our confidence in this finding is low.
One-off versus repeated intervention sessions
As above, we could not perform subgroup analysis for inhaler
technique score, as we chose not to combine results, and the only
studies reporting asthma control delivered repeated sessions. For
dichotomised inhaler technique, the formal test for subgroup dif-
ferences in both adults and children (Analysis 1.10; Analysis 2.4)
did not suggest any impact of repeated versus one-off sessions of
education, but as above, very few studies contributed to these anal-
yses.
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Comparisons 3 and 4: multi-media training versus
control or usual care
Five studies in adults (Self 1983; Lirsac 1991; Savage 2003;
Goodyer 2006; Acosta 2009) and two studies in children (Boone
2002; Carpenter 2015) contributed to this comparison.
Inhaler technique
Again, investigators usually measured inhaler technique by using
a checklist, immediately after the intervention or at follow-up.
Two further linked studies in separate populations reported “global
improvement in technique” dichotomously immediately after the
intervention and found benefit in favour of the multi-media inter-
vention when compared with a patient information leaflet and a
verbal explanation, but the lower confidence interval of the effect
estimate does not rule out benefit for the control group (Analysis
3.1; OR 2.15, 95%CI 0.84 to 5.50; 164 participants; two studies;
I² = 49%; moderate-quality evidence).
One study reporting number with correct use after 15 days found
no significant differences between groups, although this study in-
cluded too small a sample to permit firm conclusions (Analysis
3.2; OR 1.78, 95% CI 0.40 to 7.94; low-quality evidence).
Two studies in adults reported themean between-group difference
immediately after the intervention or after follow-up (or both) as
“percent correct use” or as a score out of 20. We decided not to
combine these results. Both studies demonstrated benefit of multi-
media training versus usual care (Analysis 3.3).
Two studies in children also reported change from baseline inhaler
technique at one-month follow-upby using a checklist.Wepresent
these effect estimates in a data table and did not include them in a
meta-analysis (Analysis 4.1). Both studies show benefit of multi-
media training.
Asthma control
Only one study in children reported asthma control using the
ACT, both as an endpoint score and as change frombaseline (Anal-
ysis 4.2; Analysis 4.3), and found no significant between-group
differences, with confidence intervals excluding the established
minimal clinically important difference (MCID) of 3 (low-quality
evidence).
No studies in this comparison reported the following outcomes
in a way that allowed meta-analysis: exacerbations; quality of life;
adverse events; unscheduled visits to a health care provider; and
absenteeism from work or school.
Subgroup analysis
We were unable to perform either of our prespecified subgroup
analyses for this comparison.
Comparisons 5 and 6: feedback device versus control or
usual care
Three studies in adults (Al-Showair 2007; Ammari 2013; Toumas-
Shehata 2014) and four studies in children (Schultz 2012; Ammari
2013; Ammari 2015; Ammari 2015a) contributed to at least one
meta-analysis (Ammari 2013 recruited both adults and children
and presented disaggregated results for quality of life).
Inhaler technique
Study authors assessed inhaler technique in both adults and chil-
dren using peak inspiratory flow (PIF) rate. DPIs require fast, deep
inhalation (high PIF rate), and MDIs require a slower, deep in-
halation (low PIF rate).
One small study in adults measured this dichotomously at six
weeks with participants classified as achieving or not achieving
the optimal rate of < 90 L/min. Results showed benefit in favour
of the feedback device, but the effect was very imprecise (Analy-
sis 5.1; OR 18.26, 95% CI 2.22 to 150.13; 71 participants; one
study; low-quality evidence). Another study, in which pharmacists
in the intervention group used an inhaler device to give quantita-
tive feedback on inhaler technique to participants, dichotomised
participants into those with correct technique and those without
incorrect technique at four weeks. Use of an inhaler feedback de-
vice in addition to verbal training increased the odds of achiev-
ing the correct technique (Analysis 5.2: OR 4.80, 95% CI 1.87
to 12.33; 97 participants; one study; low-quality evidence). This
equates to 51 out of 100 people having correct technique at four-
week follow-up in the control group compared with 83 out of 100
(95% CI 66 to 93) in the active intervention group.
Two small studies in children assessed PIF rate as a continuous
variable (L/min) at follow-up between 6 and 12 weeks. As these
studies were assessing MDI technique, slower inhalation (lower
PIF rate) was preferred. Combined results do not show clear ben-
efit of the intervention, although the confidence intervals do not
rule out benefit or harm (Analysis 6.1; MD -9.22, 95% CI -33.71
to 15.27; 98 participants; two studies; I² = 42%; low-quality evi-
dence).
Asthma control
One study measured asthma control using the ACQ at four weeks
and found no differences between groups and confidence intervals,
excluding the MCID of 0.5 (Analysis 5.4: MD -0.10, 95% CI -
0.46 to 0.26; 97 participants; one study; low-quality evidence).
Two studies in childrenmeasured this using the ACQ at between 6
and 12 weeks. Investigators noted no between-group differences,
with confidence intervals again excluding theMCID of 0.5 (Anal-
ysis 6.2; MD -0.02, 95% CI -0.35 to 0.32; 98 participants; two
studies; I² = 0%; moderate-quality evidence).
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Quality of life
Two studies in adults reported quality of life; both used the mini-
AQLQ and measured this outcome at six weeks. Pooled analysis
suggests benefit of device feedback over usual care. However, the
mean difference falls below the MCID of 0.5, and the lower con-
fidence interval includes no difference (Analysis 5.5; MD 0.38,
95%CI -0.01 to 0.77; 100 participants; two studies; I² = 0%; low-
quality evidence). One of the two studies also reported the mini-
AQLQ as a “responder analysis” (i.e. those experiencing at least a
0.5 point improvement), which shows clear, although imprecise,
benefit of the intervention (Analysis 5.6; OR 5.29, 95% CI 1.76
to 15.89; 71 participants; one study; moderate-quality evidence).
This equates to 49 out of 100 people having a greater than 0.5
point improvement at six-week follow up in the control group
compared with 83 out of 100 (95% CI 42 to 94) in the active
intervention group (Figure 4).
Figure 4. In the control group, 49 out of 100 people had at least 0.5 unit increase in AQLQ after 6 weeks,
compared with 83 (95% CI 42 to 94) out of 100 in the active treatment group.
Among children, three studies reported quality of life - two us-
ing the paediatric AQLQ (PAQLQ) and one using the PedsQL
Asthma Module. We pooled the two studies reporting PAQLQ
as a change from baseline; results show benefit in favour of the
feedback device, but the lower confidence interval includes no
difference (of note, in one of the studies, reported quality of life
deteriorated in both groups, just less so in the feedback device
group) (Analysis 6.3; MD 0.25, 95% CI -0.07 to 0.58; 91 par-
ticipants; two studies; I² = 20%; low-quality evidence). Schultz
2012 reported quality of life on the PedsQL (Asthma Module) at
three months and did not detect any significant between-group
differences (Analysis 6.4; MD 41.00, 95% CI -76.49 to 158.49;
109 participants; one study), but the result was imprecise.
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Researchers did not report the following outcomes in a way that
allowed meta-analysis in this comparison: exacerbations; adverse
events; unscheduled visits to a healthcare provider; and absen-
teeism from work or school.
Subgroup analysis
We were unable to perform either of our prespecified subgroup
analyses for this comparison.
Sensitivity analyses
We did not perform prespecified sensitivity analyses for the fol-
lowing reasons.
1. We did not obtain any unpublished data.
2. The only trial deemed at high risk of selection bias (Shah
2014) did not contribute data to any meta-analysis.
3. Almost all trials that contributed data on inhaler technique
used a standard or validated checklist to assess inhaler technique,
or they used an objective measure such as PIF rate. For only one
contributing study (Acosta 2009), we could not determine how
inhaler technique had been assessed. This information was
provided as a conference abstract that reported percentage
“correct usage” of inhaler; it is not clear whether this refers to the
number of individuals who used the device correctly, or to the
mean percentage of correct steps followed by each participant.
However, as we decided not to pool checklist scores owing to
extremely high statistical heterogeneity and heavily skewed data,
we determined that the planned sensitivity analysis was not
necessary.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
M ultimedia training compared with control/ usual care for people with asthma
Patient or population: adults and children with asthma
Setting: primary and secondary care
Intervention: mult i-media training
Comparison: control/ usual care
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
Number of partici-
pants
(studies)
Quality of the evi-
dence
(GRADE)
Comments
Risk with control/
usual care
Risk with multi-media
training
Correct inhaler
technique
Immediately af ter in-
tervent ion
Adults 30 per 100 47 per 100
(26 to 70)
OR 2.15
(0.84 to 5.50)
164
(2 RCTs)
⊕⊕⊕©
M ODERATEa,b
Correct inhaler
technique
2-Week follow-up
Adults 43 per 100 57 per 100
(23 to 86)
OR 1.78
(0.40 to 7.94)
28
(1 RCT)
⊕⊕©©
LOWa,c
Inhaler technique
score
Adults Not pooled; narrat ive summary of evidence
provided in data table (Analysis 3.3)
- 136
(2 RCTs)
Not graded Suggests benef it of
mult i-media training
over control
Children Not pooled; narrat ive summary of evidence
provided in data table (Analysis 4.1)
- 127
(2 RCTs)
Not graded Suggests benef it of
mult i-media training
over control
Asthma control
(ACT)
4 weeks
Children Mean change in con-
trol group was 1.2
Mean change was 0.
73 better
(-0.99 worse to 2.45
better)
- 91
(1 RCT)
⊕⊕©©
LOWa,c
Other outcomes No results could be analysed for quality of lif e, exacerbat ions, adverse events, unscheduled visits to a healthcare provider or school/ work absences2
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* The risk in the intervention group (and its 95% conf idence interval) is based on assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%
CI)
ACT: Asthma Control Test (range 0 to 25; higher is better); CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial; RR: risk rat io; SDs: standard deviat ions
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to the est imate of ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of ef fect but may be substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aConf idence intervals include no dif ference. Downgraded once
bAlthough part icipants in both studies were unblinded, inhaler technique was rated by a blinded assessor, and both groups
received an intervent ion. Not downgraded
cHigh risk of bias for performance and detect ion. Downgraded once
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Feedback device compared with control/ usual care for people with asthma
Patient or population: adults and children with asthma
Setting: primary and secondary care
Intervention: f eedback device
Comparison: control/ usual care
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
Number of partici-
pants
(studies)
Quality of the evi-
dence
(GRADE)
Comments
Risk with control/
usual care
Risk with feedback
device
Correct inhaler
technique
4-Week follow-up
Adults 51 per 100 83 per 100
(66 to 93)
OR 4.80 (1.87 to 12.
33)
97
(1 RCT)
⊕⊕©©
LOWa,b
Addit ional results
f rom technique rat ing
scales could not be
combined (Analysis 5.
3)
Inhaler technique
(PIF)
Follow-up:
6 weeks (adults)
6 to 12 weeks (chil-
dren)
Adults 66 per 100 97 per 100
(81 to 100)
OR 18.26
(2.22 to 150.13)
71
(1 RCT)
⊕⊕©©
LOWa,b
Children Mean PIF was 51.2
litres/ min
Mean PIF was 9.22
litres/ min better (33.
71 better to 15.27
worse)
- 98
(2 RCTs)
⊕⊕©©
LOWa,c
Asthma control
(ACQ)
6 to 12 weeks
Adults Mean ACQ score was
1.4
Mean score in the in-
tervent ion group was
0.1 better
(0.46 better to 0.26
worse)
- 97
(1 RCT)
⊕⊕©©
LOWa,c
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Children Mean ACQ score was
0.7
Mean score in the in-
tervent ion group was
0.02 worse
(0.35 worse to 0.32
better)
- 98
(2 RCTs)
⊕⊕⊕©
M ODERATEa
Quality of life
Follow-up:
6 weeks (adults)
6 to 12 weeks (chil-
dren)
Adults Mean score on the
mini-AQLQ was 4.2
Mean score in the in-
tervent ion group was
0.38 better
(0.01 worse to 0.77
better)
- 100
(2 RCTs)
⊕⊕©©
LOWa,d
Children Mean change in qual-
ity of lif e was 0.07
Mean change was 0.
25 better
(0.07 worse to 0.58
better)
- 91
(2 RCTs)
⊕⊕©©
LOWa,d
One study reported
endpoint quality of lif e
(Analysis 6.4)
Quality of life (re-
sponders)
6 weeks
Adults 49 per 100 83 per 100
(62 to 94)
OR 5.29
(1.76 to 15.89)
71
(1 RCT)
⊕⊕⊕©
M ODERATEa
Other outcomes No results could be analysed for exacerbat ions, adverse events, unscheduled visits to a healthcare provider or school/ work absences
* The risk in the intervention group (and its 95% conf idence interval) is based on assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%
CI)
ACQ: Asthma Control Quest ionnaire (range 0 to 6; lower is better); CI: conf idence interval; OR: odds rat io; PIF: peak inspiratory f low; RCT: randomised controlled trial; RR: risk
rat io; SDs: standard deviat ions
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to the est imate of ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of ef fect but may be substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aHigh risk of performance and detect ion bias. Downgraded once
bVery wide conf idence intervals based on one study. Downgraded once
cConf idence intervals include possible harm and benef it of the intervent ion. Downgraded once
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dConf idence interval does not exclude no dif ference, and upper lim it exceeds the MCID of 0.5 units. Downgraded once
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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D I S C U S S I O N
Summary of main results
This review includes 29 parallel randomised controlled trials
(RCTs; n = 2210), although not all trials reported relevant or use-
able data. All participants had asthma, and some studies specified
use of a particular inhaler or spacer, or required a particular level
of asthma control. Follow-up of analysed studies ranged from 2 to
26 weeks. Studies used a variety of scales and did not always use
validated scales. Almost all included studies reported some mea-
sure of inhaler technique on a range of different checklists. Most
studies were at low or unclear risk of selection and attrition biases
and at high risk of biases associated with blinding. We considered
most of the evidence to be of low quality owing to these biases and
to imprecision in the estimates of effect.
Most studies were classified into three comparisons: those assess-
ing an enhanced face-to-face training session(s), those using multi-
media to deliver inhaler training (e.g. a video, computer app or
game) and those testing devices that give people visual or audio
feedback about technique. Despite the large number of included
studies, these differences between interventions, as well as differ-
ences in age groups and outcome measures, meant that meta-anal-
yses often could not be performed. This was particularly true for
exacerbations, adverse events, unscheduled visits to a healthcare
provider and absenteeism from work or school.
Enhanced inhaler technique education and multi-media training
led to improved technique inmost studies immediately after the in-
tervention and at follow-up, although the variety of checklists used
meant that this was difficult to assess reliably. For both adults and
children, how and when inhaler technique was assessed appeared
to affect whether inhaler technique improved and by how much.
Analyses of the numbers of people who demonstrated correct or
’good enough’ technique were generally more useful; adult studies
of enhanced education showed benefit with this metric (odds ratio
(OR) 5.00, 95% confidence interval (CI) 1.83 to 13.65; 258 par-
ticipants; three studies), as did analyses looking at feedback devices
(OR 4.80, 95% CI 1.87 to 12.33; 97 participants; one study),
but the benefit of multi-media training for adults was uncertain
(OR 2.15, 95% CI 0.84 to 5.50; 164 participants; two studies;
I² = 49%). Evidence tended to be less clear for children, usually
because results were based on fewer and smaller studies.
Studies found some benefit for quality of life and asthma con-
trol, but results generally did not indicate consistent or impor-
tant benefits of inhaler technique interventions for adults or chil-
dren. Confidence intervals included no difference or fell under a
range that could be considered clinically important. Responder
analyses sometimes showed that more people in the intervention
groups saw improvement, even though the mean difference be-
tween groups was small.
Overall completeness and applicability of
evidence
Most of the studies included in this review showed that an inter-
vention to improve inhaler technique improved technique when
assessed by a checklist or dichotomously. This was true for both
adults and children with asthma and across the three main types
of interventions included in the review. However, interventions
used in the included studies were variable, even within the three
main comparisons that we have identified. Investigators measured
outcomes at different time points and in different ways; thus we
have limited confidence in how our findings can be applied to the
real-life setting. A checklist score is not necessarily the most useful
measure for clinicians; not all items on the checklist are equally
important for achieving medication delivery, and this distinction
is not clear when mean scores alone are reported. For example,
failing to remove an inhaler cap is a critical error, whereas fail-
ing to hold the inhaler upright might not be so critical. A more
useful measure, reported by a minority of included studies, is a
dichotomous outcome that reports the number of people with (or
without) a critical inhaler handling error. We know that critical
errors are common, ranging in one study from 12% to 44% of
users (depending on inhaler type), and are associated with poorer
outcomes (Melani 2011).
In addition, many included studies have treated checklist scores as
continuous variables and have used parametric statistical tests, but
these measures are clearly skewed, and the wisdom of this analysis
choice could be questioned. As a result of the skew and the hetero-
geneity of the measurement tools used, we chose not to perform
meta-analyses of checklist outcomes and instead reported these
outcomes in data tables. Our inability to pool inhaler technique
measurements for most of the included studies has considerably
limited the conclusions that we can reach.
Another limitation to the applicability of our findings is that we
were unable to perform most of our planned subgroup and sen-
sitivity analyses, or, when we were able, our subgroups included
very few studies, limiting our confidence in the findings. This
means that we cannot comment on whether multiple interven-
tion sessions are superior to one-off sessions, or whether delivering
the intervention to a healthcare professional (e.g. a pharmacist) is
more or less effective than delivering the intervention directly to
the patient. These are important issues, as the feasibility of larger-
scale implementation would be affected by such intervention de-
sign details.
Improvements in inhaler technique observed in many of the in-
cluded studies did not always translate to any meaningful benefit
for patient-important outcomes, such as exacerbations and quality
of life. In some cases, these outcomes were simply not measured;
in other cases, studies may not have been powered, or were of in-
sufficient duration, to detect a difference. The maximum duration
of follow-up was only 26 weeks (three studies), and many trials
had a much shorter duration. Also, as discussed above, although
many participants were performing steps more correctly, they still
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might have been making critical errors that prevented improved
drug delivery and therefore limited clinical improvement.
Another important consideration when the applicability of the ev-
idence is assessed is whether such interventions could be delivered
realistically in routine clinical practice. Many healthcare systems
are under strain, and healthcare professionals may have only a few
minutes to spend with each patient. In view of the time-consum-
ing nature of many of the interventions investigated in this review,
it is even more essential for researchers to demonstrate that clear
clinical benefit can be expected from this investment of resources.
Of note, only 10 of the 29 studies included in this review were
published within the past five years, and of these, only six con-
tributed data to at least one meta-analysis.
An alternative explanation for the lack of clinical improvement
would be that very few of the included studies attempted to ad-
dress adherence; even a participant who can demonstrate correct
technique at follow-upmay not have been adherent to themedica-
tion regimen during the follow-up period. Inadequate adherence
to prescribedmedication is thought to have contributed to approx-
imately one-third of asthma deaths in the UK over the course of a
year (NRAD2014). An intervention to improve inhaler technique
could be considered incomplete unless it also includes an attempt
to address adherence. However, our protocol clearly stated that we
would include only studies for which improving inhaler technique
was the main aim, and adherence is the topic of another Cochrane
Review. This resulted in the exclusion of many studies for which
inhaler technique training was just one component of a broader
self-management or asthma education intervention. As a result,
we may have excluded studies that would have been informative
in a ’real-world’ setting, but their inclusion would have further
hampered interpretation of findings. It would be very difficult to
assess which element of the intervention had led to any observed
clinical benefit.
Some included studies specifically recruited people known to have
poor inhaler technique or people with poorly controlled asthma.
We did not plan to analyse people with poorly controlled asthma
separately from those with better controlled asthma. Greater im-
provements might have been seen in this group than in a more
general asthma population, and this might help in terms of target-
ing a potentially expensive and time-consuming intervention in
clinical practice. Review authors could consider such a subgroup
analysis for future updates of this review.
Quality of the evidence
Most of the evidence that could be combined and graded was
related to inhaler technique, asthma control and quality of life.
For all of these outcomes, risk of performance and detection bias
may have led to an overestimation of treatment effects. Although
it was not possible to blind the delivery of behavioural interven-
tions within studies, it would have been possible to control for
detection bias by blinding those who assessed inhaler technique
at the end of the study; in most cases, this was not done. Across
comparisons and outcomes, we downgraded evidence quality for
this reason unless it was clear that a particular outcome had been
assessed independently (e.g. inhaler technique in Goodyer 2006
and Savage 2003). We were more confident in results from studies
in which the control group received additional support or an ac-
tive control intervention, as this would have minimised the effects
of performance bias. For outcomes for which risk of bias was our
only concern, we had moderate confidence in the results, meaning
that the true effect is likely to be close to that estimated. This was
true for inhaler technique in adults given enhanced and multi-
media training, and for responder analyses of asthma control and
quality of life.
Our confidence in results was also reduced by imprecision of es-
timates for which confidence intervals did not exclude the pos-
sibility of the effect favouring the control group. This took our
confidence in the evidence down to low, which was the most com-
mon rating across outcomes. This means that our confidence in
the effect estimates is limited, and that the true effect may be sub-
stantially different from that estimated from the current evidence.
When we noted inconsistency between results, we further down-
graded the evidence to very low quality; we did this for the effect
of enhanced training on asthma control in adults (comparison 1).
We did not apply GRADE criteria to outcomes for which we
could not perform a meta-analysis, including those for which data
were available but we considered it unreasonable to pool results.
In these cases, particularly for inhaler technique checklist scores,
the results are very difficult to interpret owing to inconsistencies
in measurement and non-parametric properties of the data.
Potential biases in the review process
We followed the methods described in the published protocol (
Normansell 2016) and recorded any deviations in the section titled
Differences between protocol and review. We made some changes
to the division of the workload, but the main deviation from the
protocol was result of insufficient data, which prevented several
planned meta-analyses. This is discussed in Overall completeness
and applicability of evidence.
We did not know in advance how studies would vary, particularly
with regard to interventions delivered and the nature of control
groups. As a result, the method of grouping studies into compar-
isons was iterative and was based on the judgement of the review
authors. We stated in the protocol that we would conduct meta-
analyses only “if treatments, participants and the underlying clin-
ical question were similar enough for pooling to make sense”. We
have been transparent about which studies were included in each
comparison but we accept that the post hoc nature of this process
could have introduced bias.
Usually we would contact study authors to ask for additional out-
come data and to clarify uncertainties about risk of bias, so we
could be certain that the evidence is reliable and complete. Owing
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to the large number of studies identified, we did not contact study
authors routinely for this information and contacted teams only
if we wished to clarify specific issues related to outcome data. We
did not request unpublished data, so analyses may be incomplete
if studies did not include all of their outcomes or time points in
the published reports. We assessed several studies to be at high risk
of bias for selective outcome reporting, but we did not strongly
suspect that publication bias compromised the meta-analyses we
were able to perform.
Agreements and disagreements with other
studies or reviews
Poor inhaler technique is a common and burdensome problem,
and several primary studies previously evaluated interventions to
improve inhaler technique among both children and adults with
asthma. The variety of interventions assessed and outcomes pre-
sented in the primary studies posed significant challenges for our
review. Previous relevant systematic reviews identified similar is-
sues. Gillette 2016 evaluated educational interventions to improve
inhalation technique among children with asthma on the basis of
results obtained from 28 studies. Lavorini 2007 assessed the effect
of incorrect use of dry powder inhalers on the treatment of patients
with asthma and chronic obstructive pulmonary disease (COPD);
this review included 47 relevant primary studies. Both of these re-
views identified significant variation in the proportion of patients
correctly using their inhalers, which was associated with the use of
different inhaler devices and different evaluation methods. In our
review, we did not assess differences among devices. Both previous
reviews also concluded that appropriate inhaler technique instruc-
tion leads to significant but short-lived improvement in inhalation
technique. Our review detected a trend towards prolonged benefit
compared with control. However, this finding is based on very
limited data, and confirmatory trials are required. In the mean-
time, as suggested by previous systematic reviews, correct inhaler
technique should be reassessed and reinforced regularly. Finally,
although Lavorini 2007 describes only incorrect inhaler technique
and whether or not patients received adequate instruction, Gillette
2016 identified a variety of educational interventions with differ-
ent efficacy, which is consistent with our findings.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The studies included in this review have examined a variety of
interventions, and although many studies report an improvement
in checklist score or a greater number of people with correct tech-
nique, these results do not clearly translate into clinical benefit;
very few studies have reported adverse events. Clinical guidelines
consistently recommend that practitioners regularly check that
their patients with asthma are using the correct inhaler technique,
and evidence suggests that poor technique is associated with worse
clinical outcomes. Until larger and longer trials detect consistent
improvement in clinical outcomes after a specific inhaler tech-
nique intervention, it is reasonable for practitioners to continue to
ask their patients regularly to demonstrate their inhaler use and to
correct their technique when possible, or refer patients for a local
inhaler technique intervention.
Implications for research
Many of the studies included in this review are at least 10 years
old, and only 10 have been published within the past five years,
suggesting that the evidence base is somewhat dated. Future trials
should be adequately powered and of sufficient duration (ideally
should last at least six months) to detect clinical improvements
and possible harms. Although standardised checklists provide a
useful measure, it would be helpful if more triallists report the
number of participants achieving an adequate technique, or not
performing any critical errors, as this information may serve as a
more meaningful measure and would allow increased meta-analy-
sis. Ideally, inhaler technique should be assessed by a person blind
to group allocation, and triallists should clearly report baseline
asthma severity and medication use. Given that many of the in-
terventions in this review are likely to be expensive, an economic
evaluation would be a useful addition to future studies. Triallists
might also consider measuring and reporting adherence to inhaled
medication during these trials; this would help to clarify whether
improved adherence led to observed benefits, or whether adher-
ence was insufficient for improved technique to have any impact
on clinical outcomes.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Acosta 2009
Methods Design: single-blind parallel-group randomised controlled trial
Duration: 4 weeks
Setting: USA
Trial registration: not reported
Participants Population: 133 people with asthma randomised to an MDI inhaler technique training
video or an asthma education video (n per group not reported)
Age: “adults”
Baseline asthma severity: not reported
Inclusion criteria: “asthma patients”
Exclusion criteria: not reported
Percentage withdrawn: not reported per group; 17/133 (13%) did not complete trial
Other allowed medication: not reported
Interventions Intervention summary: MDI training video shown at index visit with pre and post
assessment of inhaler technique, with follow-up at 1 month
Control summary: asthma education video shown at index visit with pre and post
assessment of inhaler technique, with follow-up at 1 month
Outcomes Outcomes measured: “correct usage”
Technique assessment method used: not reported
Notes Type of publication: conference abstract
Funding: not reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patientswere randomized” - no further de-
tails of sequence generation
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “The examiner (who assessed inhaler tech-
nique) was blinded to the intervention”
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Acosta 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Although 116/133 (87%) participants
completed the trial, the drop-out for each
arm is not reported
Selective reporting (reporting bias) High risk No prospective trial registration identified.
Minimal details as reported, as conference
abstract only. Unclear how “correct tech-
nique” was assessed
Other bias Low risk None noted
Agertoft 1998
Methods Design: single-blind parallel-group randomised controlled trial
Duration: 2 weeks
Setting: 1 outpatient clinic in Denmark
Trial registration: not reported
Participants Population: 72 children with asthma randomised to hospital and home training (n =
36) or hospital training alone (n = 36)
Age: children aged 3 to 5 years; mean age 54 months (range 36 to 71 months)
Baseline asthma severity: not reported
Inclusion criteria: preschool children aged 3 to 5 years. All had bronchial asthma and
were receiving inhaled anti-inflammatory therapy through a pMDI and spacer
Exclusion criteria: children with acute wheeze
Percentage withdrawn: 0% of participants withdrew from the intervention group and
3% from the control group
Other allowed medication: All children continued their regular antiasthma therapy
throughout the course of the study
Interventions Intervention summary: instructional video followed by instructional pamphlet con-
tained in the commercially available Turbuhaler package. Intervention group children
then received individual training from a nurse and a placebo inhaler to practice with at
home over the next 2 weeks
Control summary: instructional video followed by instructional pamphlet contained in
the commercially available Turbuhaler package
Outcomes Outcomes measured: lung function measures: peak inspiratory flow (PIF) and inspi-
ratory vital capacity (IVC). Peak expiratory flow rate (PEF), forced expiratory volume
in 1 second (FEV1) and forced vital capacity (FVC) were measured “for demographic
purposes only”
Technique assessment method used: PIF was used as a measure of inhaler technique
Notes Type of publication: single peer-reviewed journal article
Funding: not reported
Risk of bias Risk of bias
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Agertoft 1998 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “At study entry, the children were strati-
fied by age and randomly allocated to one
of two study groups”. It not clear how the
sequence was generated for randomisation
after stratification by age
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Children, caregivers and personnel could
not be blinded owing to nature of interven-
tion. However, given the young age of chil-
dren and the objective nature of the out-
come measures (lung function), it is un-
likely that knowledge of group allocation
had an impact on their performance, be-
yond the impact intended by the interven-
tion
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The trial is described as single-blind. “The
investigator conducting all inspiratory and
expiratory lung function testing was un-
aware of the level of training received by
each child after the initial basic clinic train-
ing”. In addition, lung function measures
are relatively objective and are not at high
risk of detection bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 1 child in the control group was with-
drawn from the trial by parents
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified.
Baseline characteristics table missing, so
unable to assess baseline imbalances objec-
tively, although text states that groups were
balanced. All outcomes listed in Methods
reported in the text
Other bias Low risk None noted
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Al-Showair 2007
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 6 weeks
Setting: 1 outpatient clinic, UK
Trial registration: not reported
Participants Population: 108 people with asthma randomised to verbal training plus 2Tone Trainer
(n = 36) or verbal training alone (n = 36)
Age: mean age (SD) in the intervention group 58.3 (13.7) years, and in the control
group 52.6 (16.7) years
Baseline asthma severity: intervention group: FEV1 % predicted (SD) 71.4 (22.0);
mini-AQLQ (SD) 3.8 (1.1). Control group: FEV1 % predicted (SD) 76.9 (24.1); mini-
AQLQ (SD) 3.9 (1.0)
Inclusion criteria: Patients with asthma who were attending an outpatient clinic were
invited to take part in this study. Each patient had to be receiving an inhaled corticosteroid
from an MDI without a spacer device. Patients with adequate co-ordination but too
rapid inspiratory flow were randomised to 1 of the 2 intervention groups
Exclusion criteria: patients who had experienced an acute exacerbation in the past 4
weeks; patients who were deaf or unable to distinguish between 1 and 2 tones with the
2T; patients with poor inhaler co-ordination who were ineligible for the study and were
referred to the asthma nurse for inhaler technique training
Percentage withdrawn: 0% of participants withdrew from the intervention group, and
3% from the control group
Other allowed medication: “There were no changes to patients’ prescriptions”
Interventions Intervention summary: The 2Tone Trainer looks like an MDI but does not have a
canister, so that when it is used, the patient does not receive a dose. During use, this
training aid provides users with audible feedback according to the patient’s inhalation
rate. It makes a 2-tone sound when the patient is inhaling at 60 L/min, 1 tone when
inhaling between 30 and 60 L/min and no sound when inhaling at 30 L/min. Patients
are advised to obtain the 1-tone noise and thus become accustomed to the degree of
inspiratory effort they need to make to achieve this rate through an MDI. Participants
were given a 2Tone Trainer to use at home and received the same verbal training as the
verbal training alone group
Control summary: Verbal training participants were trained on the most desirable in-
halation technique with emphasis on breathing out slowly as far as comfortable and
actuating a dose at or soon after the start of a slow inhalation. A slow inhalation was
defined as an inhalation that filled the lungs with air that lasted 5 seconds
Outcomes Outcomes measured: peak inspiratory flow (PIF), FEV1 and quality of life (AQLQ)
Technique assessment method used: PIF was used as a measure of inhaler technique
Notes Type of publication: single peer-reviewed journal article plus 2 conference abstracts
Funding: 2Tone Trainers were donated by Canday Medical Ltd. Dr Al-Showair was
financially supported by a scholarship from the Saudi Arabian Government, and the
study was part of his PhD
thesis
Risk of bias Risk of bias
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Al-Showair 2007 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Subjects in the intervention group were
randomly allocated into the verbal training
(VT) group or the 2T group” - no further
details of sequence generation
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No description of procedures intended to
blind outcome assessors to group assign-
ment; for outcomes such as AQLQ, the
participant/caregiver is the outcome asses-
sor; therefore these outcomes may be at risk
of detection bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 1 participant withdrew from the
study
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified.
However, all outcomes listed in Methods
clearly reported in paper
Other bias Low risk None noted
Ammari 2013
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 6 weeks
Setting: 1 outpatient clinic, UK
Trial registration: not reported
Participants Population: 56 people with asthma randomised to 2 Tone Trainer (2TT) group (n = 23;
17 adults, 6 children) or verbal counselling (VC) group (n = 23; 17 adults, 6 children)
. Children with adequate technique at initial assessment formed the “control” group
(not of interest in this study, as not randomised) (we have assigned the 2TT as the
“intervention” arm and the VC as the “control” arm)
Age: 4 to 55 years; mean (SD) age in the intervention group: adults 38.5 (10.8) years,
children 11.7 (2.4) years; and in the control group: adults 42.4 (7.2) years, children 11.
2 (2.4) years
Baseline asthma severity: “Mild-moderate-severe asthma, according to GINA 2008”
Inclusion criteria: 4 to 55-year-old asthmatic patients prescribed at least 1MDI without
spacer
Exclusion criteria: experienced an acute exacerbation or received oral prednisolone
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within 4 weeks before recruitment, other illnesses adversely affecting respiratory system,
hearing problems and/or unable to distinguish between 1 and 2 tones produced by the
2TT tool
Percentagewithdrawn:12%adults, 0%childrenwithdrew from the intervention (2TT)
arm; 18% adults and 17% children withdrew from the “control” (VC) arm
Other allowed medication: not reported
Interventions Intervention summary: verbal training plus use of 2 Tone Trainer (2TT) device, which
participants were able to take home. 2TT is a training aid with audible feedback when
the required slow inhalation flow is used
Control summary: verbal training with emphasis on inspiratory flow rate
Outcomes Outcomes measured: lung function measures: change in FEV1; inhalation flow rate;
QOL: Juniper’s Asthma QOL Questionnaire (AQLQ): adults - Mini AQLQ; children -
PAQLQ; PACQLQ by parents of children
Technique assessment method used: PIF was used as a measure of inhaler technique
Notes Type of publication: single peer-reviewed journal article
Funding: not reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “…based on a previously constructed ran-
domization table”
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No description of procedures intended to
blind outcome assessors to group assign-
ment; for outcomes such as AQLQ, par-
ticipant/caregiver is the outcome assessor;
therefore these outcomes may be at risk of
detection bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk 56 asthmatic patients enrolled and 50 com-
pleted the 2 study visits as per protocol.
Balanced drop-out
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified.
No power analysis reported. Outcomes
listed in Methods all reported in the text
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Other bias Low risk None noted
Ammari 2015
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 12 weeks
Setting: paediatric respiratory outpatient clinics at NHS teaching hospitals in UK
Trial registration: not reported
Participants Population: 80 children with asthma randomised to AeroChamber Plus with Flow-Vu
(FV) (n = 40) or AeroChamber Plus (AC) (n = 40)
Age: children aged 1 to 5 years; mean age (SD) in the intervention group 2.8 (0.93)
years, and in the control group 3.4 (1.09) years
Baseline asthma severity: intervention group: “partly controlled - or uncontrolled
asthma”; baseline ACQ (SD): 1.75 (0.54); PAQLQ (total) (SD): 5.34 (0.90). Control
group: “partly controlled - or uncontrolled asthma”; baseline ACQ (SD): 1.91 (1.11);
PAQLQ (total) (SD): 4.97 (1.05)
Inclusion criteria: children aged 1 to 5 years with partially controlled or uncontrolled
asthma according to GINA (2008) criteria and receiving parentally supervised inhalation
therapy, including an inhaled corticosteroid, via a pMDI plus a spacer device
Exclusion criteria: inhalation treatment had been changed over the 4 weeks before
enrolment, using a dry powder inhaler or a breath-activated pMDI, limited physical or
mental ability to use a spacer or to follow study procedures, had other chronic disease
conditions at study enrolment that might adversely affect their quality of life
Percentage withdrawn: No participants withdrew from the trial
Other allowed medication: “No change in the asthma medications was recorded for all
participants throughout the study period”
Interventions Intervention summary: AeroChamber Plus with Flow-Vu: designed with a visual feed-
back reassurance mechanism of an optimal inhalation; 4 visits over 12 weeks; visit 1
training given on correct use of AC. Randomisation occurred at visit 2, during which
training on correct use of FV was given. 2 further follow-up visits at 6 and 12 weeks post
randomisation
Control summary: currently available AeroChamber device, which does not have the
visual feedback indicator; 4 visits over 12 weeks; visit 1 training given on correct use of
AC. Randomisation occurred at visit 2, with further training on use of AC provided. 2
further follow-up visits at 6 and 12 weeks post randomisation
Outcomes Outcomes measured: peak inspiratory flow (PIF), quality of life (PAQLQ), asthma
control (ACQ), parent spacer preference on Likert scale
Technique assessment method used: PIF was used as a measure of inhaler technique
Notes Type of publication: single peer-reviewed journal article
Funding: Trudell Medical International, Canada: unconditional grant for the use of
facilities at clinics used in the study
Risk of bias Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The children were randomised to use the
AC or the FV according to a pre-study de-
signed randomisation table”
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment; outcomes such as PAQLQ and
ACQ are subjective and may be at risk of
performance bias
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No description of procedures intended to
blind outcome assessors to group assign-
ment; for outcomes such as PAQLQ and
ACQ, participant/caregiver was the out-
come assessor; therefore these outcomes
may be at risk of detection bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk No drop-out
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified.
However, all outcomes listed in Methods
clearly reported in paper
Other bias Low risk None noted
Ammari 2015a
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 6 to 8 weeks
Setting: not reported
Trial registration: not reported
Participants Population: 30 children with asthma randomised to Trainhaler (TH) group (n = 9) or
verbal counselling (VC) group (n = 9). Children with adequate inhaler technique formed
a “control” group (n = 12) (not of interest in this review, as not randomised; we have
assigned the TH as the “intervention” arm and the VC as the “control” arm)
Age: aged 7 to 17 years; mean age (SD) in the intervention group 9.9 (1.3) years, and
in the control group 9.9 (3.3) years
Baseline asthma severity: mean (SD) % predicted FEV1 in the intervention group 91.
2 (14.6), and in the control group 84.1 (13.9)
Inclusion criteria: asthmatic children, aged 7 to 17 years, with an MDI hand-lung co-
ordination problem including IF > 60 L/min
Exclusion criteria: not reported
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Percentage withdrawn: not reported
Other allowed medication: not reported
Interventions Intervention summary: TH group trained on and given TH to practice at home
Control summary: VC group received verbal MDI training with emphasis on using a
slow and deep inspiratory flow rate
Outcomes Outcomes measured: inhaler technique, peak IF through the inhaler, asthma control
(ACQ)
Technique assessment method used: 11-step MDI checklist
Notes Type of publication: conference abstract; does not appear to be a report of the same
study as either of the full-text reports identified for this study author
Funding: not reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomised but no details (conference ab-
stract). As with Ammari 2013 (although
different interventions and only child par-
ticipants), a control group with good tech-
nique was not included in the randomisa-
tion, and hence was not included in the re-
view
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible to blind participants and per-
sonnel to interventions given
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No mention of outcome assessor blinding
and some outcomes were self-rated (e.g.
ACQ), so could have been biased by knowl-
edge of group allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No mention of drop-outs; conference ab-
stract that does not appear to describe the
same study as others reported by this study
author
Selective reporting (reporting bias) High risk ACQ data can be extracted from the ab-
stract and included in the review, but lack of
a full publication for linkingmeanswe have
very limited information about the study
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Other bias Low risk None noted
Arthurs 2014
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 3 months
Setting: paediatric ward, Ireland
Trial registration: not reported
Participants Population: 21 children with asthma randomised to DVD inhaler instruction or indi-
vidual instruction (n for each group not reported)
Age: not reported
Baseline asthma severity: not reported
Inclusion criteria: children already using or with newly prescribed inhalers over 3
months in paediatric ward
Exclusion criteria: not reported
Percentage withdrawn: not reported
Other allowed medication: not reported
Interventions Intervention summary: DVD inhaler instruction about valved holding chamber use
Control summary: individual instruction equivalent to information in the DVD; de-
livered by a physiotherapist
Outcomes Outcomes measured: inhaler technique, self-efficacy and knowledge acquisition
Technique assessment method used: “Technique was assessed immediately post and 3
months after educationwith a newoutcomemeasure. Intra-rater and inter-rater reliability
of the new measure was examined”
Notes Type of publication: conference abstract
Funding: not reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “21 participants were randomised to DVD
or individual education” - no further details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk “Technique was assessed pre-education in
non-naive participants”. Participants and
personnel were aware of group allocation
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No mention of blinded outcome assess-
ment, but only a conference abstract avail-
able
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Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) High risk Numerical results not reported
Other bias Low risk None noted
Basheti 2005
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 2 weeks
Setting: community pharmacies, Australia
Trial registration: not reported
Participants Population: 26 people with asthma randomised to standard verbal counselling (group A)
(n = 8), augmented verbal counselling (group B) (n = 9) or augmented verbal counselling
as above, plus a physical demonstration (group C) (n = 9)
Age: mean age 42 years; range 11 to 76 years
Baseline asthma severity: across groups, at least 65% were using ICS; mild asthma =
15%, moderate asthma = 62%, severe asthma = 23%
Inclusion criteria: had asthma, had been dispensed a Turbuhaler by the recruited phar-
macist, aged 10 years or older
Exclusion criteria: did not self-administer Turbuhaler medication, did not speak or
understand English, this was first Turbuhaler prescription
Percentage withdrawn: 13% withdrew from group A, 11% from group B and 0% from
group C
Other allowed medication: not reported
Interventions Intervention summaries: Group A: instructions on Turbuhaler technique use following
the text of 2 standard items of printed material supplied by the manufacturer. One-off
session with follow-up at 2 weeks
Group B: standard verbal counselling as described above plus extra verbal information,
which included reinforcing the 4 essential steps. During both standard and augmented
verbal counselling, the researcher was careful not to use hand gestures that might act as
a surrogate physical demonstration. One-off session with follow-up at 2 weeks
Group C: verbal counselling as above, plus a physical demonstration by the researcher,
using a placebo Turbuhaler. Technique used in the physical demonstration was the
same as illustrated in the product information, with the additional component that the
Turbuhaler base was placed on a flat surface during loading. One-off session with follow-
up at 2 weeks
Outcomes Outcomes measured: inhaler technique
Technique assessment method used: 9-step Turbuhaler checklist
Notes Type of publication: peer-reviewed journal article and conference abstract
Funding: not reported
Risk of bias Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “After assessment, patients were randomly
allocated by computer-generated list to re-
ceive one of 3 types of counselling”
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment, which may have changed their
experience during the study
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No description of procedures intended to
blind outcome assessors to group assign-
ment; assessment of inhaler technique may
be at risk of detection bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 2 participants withdrew (1 from
group A and 1 from group B) for reasons
unrelated to the intervention
Selective reporting (reporting bias) High risk No prospective trial registration identified.
The only outcome listed in the Methods is
reported in paper, but some data are pre-
sented in only in graphs and cannot be
used for meta-analysis. In addition, base-
line characteristics are given for the whole
group - not for each arm - so we cannot
assess for baseline imbalances, which may
have affected response to the intervention
Other bias Low risk None noted
Basheti 2008
Methods Design: single-blind parallel-group cluster-randomised controlled trial (i.e. each ran-
domised pharmacist is a ’cluster’)
Duration: 26 weeks
Setting: community pharmacies, Australia
Trial registration: not reported
Participants Population: 31 pharmacists randomised; 97 patients with asthma subsequently enrolled.
16 pharmacists (53 patients) randomised to pharmacist-participant educational inter-
vention and inhaler technique labels; 15 pharmacists (44 participants) randomised to
peak flow measurement training (control)
Age: mean participant age (SD) in the intervention group: Diskus 51.4 (8.3) years and
Turbuhaler 45.48 (19.7) years. Mean participant age (SD) in the control group: Diskus
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41.1 (20.0) years and Turbuhaler 38.85 (18.4) years
Baseline asthma severity: intervention group: mean peak flow variability (Min%Max)
(SD) Diskus 71.5 (9.7) and Tubuhaler 74.8 (9.2); control group: mean peak flow vari-
ability (Min%Max) (SD) Diskus 76.0 (7.2) and Tubuhaler 71.2 (8.7)
Inclusion criteria: aged 14 years, doctor-diagnosed asthma, use of inhaled corticosteroid
by Turbuhaler or Diskus with or without long-acting beta2-agonist, no change in asthma
medication or dose for 1 month
Exclusion criteria: did not self-administer medication, did not speak or understand
English, were not able to return for all visits, were involved in another study
Percentage withdrawn: 1 pharmacist withdrew from the intervention group, and 3 from
the control group. 16% of participants withdrew across both groups
Other allowed medication: not reported
Interventions Intervention summary: Both groups of pharmacists educated participants on measure-
ment of peak expiratory flow (PEF) for assessment of peak flow variability. Active phar-
macists also assessed participants’ inhaler technique, without giving them feedback. At
visit 2, active pharmacists again assessed participants’ inhaler technique, then educated
participants using a specialised “Show and Tell” Inhaler Technique counselling service,
going through each step on the checklist to describe and demonstrate correct use, re-
peated up to 3 times if necessary, until the participant had correct technique on all steps.
The pharmacist then used a highlighter pen to identify incorrect steps from that day’s
initial assessment on an “Inhaler Technique Label”, which was attached to the high-
lighted label on the participant’s own controller medication inhaler. At each subsequent
visit, active pharmacists repeated inhaler technique assessment/education and placed a
new label on the participant’s replacement inhaler (or on the old one if still in use). If no
steps were incorrect on the initial assessment at any visit, the label was attached to the
participant’s inhaler with no highlighting. Five visits over 6 months
Control summary: Both groups of pharmacists educated participants on measurement
of peak expiratory flow (PEF) for assessment of peak flow variability. During the run-in
period, 1 researcher independently assessed inhaler technique for all control participants
(to establish their baseline inhaler techniquewithout providing information about correct
inhaler technique to control pharmacists). No education was provided to participants
during these assessments. For control participants, the researcher re-assessed inhaler
technique at the end of the study, then provided inhaler technique counselling
Outcomes Outcomes measured: peak flow variability, calculated as Min%Max (lowest morning
PEF over 2 weeks, as percentage of highest PEF over the same period), Inhaler Tech-
nique Score, categorisation of asthma severity based on Australian Asthma Management
Handbook, asthma-related quality of life (AQOL), perceived control (PC)
Technique assessment method used: 9-step inhaler technique checklist
Notes Type of publication: 1 conference abstract, 1 peer-reviewed journal article, 1 letter to
the editor
Funding: funded by the Faculty of Pharmacy, University of Sydney. HK Reddel was
funded by the Asthma Foundation of NSW
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk “After arrival, pharmacists were allocated
randomly by computer-generated list to
Active or Control groups”
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participating pharmacists could not be
blinded to group allocation. It is unclear
whether participants were aware of their
group allocation, although the trial is re-
ported as ’single-blind’, and control par-
ticipants did not have their inhaler tech-
nique assessed at 3 months “in order to
avoid drawing their attention to inhaler
technique”
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No description of procedures intended to
blind outcome assessors to group assign-
ment, although the study is reported as ’sin-
gle-blind’. Patient-reported outcomes may
have been affected by knowledge of group
assignment. It is not clear whether the
unblinded participating pharmacist, or a
blinded researcher, assessed objective out-
comes such as inhaler technique
Incomplete outcome data (attrition bias)
All outcomes
High risk Although only 5 pharmacists dropped out,
report states that 116 participants were en-
rolled, but only 97 returned from the sec-
ond visit, atwhich the first interventionwas
delivered. It is not clear how many partici-
pants were initially enrolled into each arm.
It is also unclear how many participants
were assessed at 6 months for each out-
come. Although it is stated that 97 ’com-
pleted the study’, the total n for those with
correct technique at the end equals 84. It is
not clear on what number the continuous
outcomes were based
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified.
All outcomes listed in Methods appear to
be reported in a peer-reviewed publication
and a letter to the editor
Other bias Low risk None noted
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Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 1 month
Setting: primary care, UK
Trial registration: not reported
Participants Population: 36 children with asthma randomised to an educational software interven-
tion (n = 17) or placebo software (control) (n = 19)
Age: children aged 7 to 11 years; mean age not given
Baseline asthma severity: not reported
Inclusion criteria: children aged 7 to 11 with asthma and with access to a personal
computer
Exclusion criteria: not reported
Percentage withdrawn: not reported
Other allowed medication: not reported
Interventions Intervention summary: an educational computer game called “Space Inhalers”, con-
taining educational material about inhaler technique and asthma information
Control summary: the same “Space Inhalers” game as in the intervention arm, but
without educational material
Outcomes Outcomes measured: inhaler technique, asthma knowledge
Technique assessment method used: measured out of 15. No other details
Notes Type of publication: conference abstract
Funding: not reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “subjects were randomised”, but no further
details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Although it is not clear whether partic-
ipants or their caregivers were aware of
whether they were receiving the active or
placebo intervention, it seems unlikely that
children in the 7 to 11 year age range were
likely to be substantially affected by perfor-
mance bias as a result of this knowledge.
The intervention took place at home, so
knowledge of allocation by trial personnel
was also unlikely to introduce bias
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No description of procedures intended to
blind outcome assessors to group alloca-
tion; therefore assessment of inhaler tech-
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nique and asthma knowledgemay be at risk
of detection bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Drop-out not reported
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified,
and trial reported only as a conference ab-
stract, so minimal details given. However,
both planned outcomes - asthma knowl-
edge and inhaler technique - are clearly re-
ported
Other bias Low risk None noted
Bynum 2001
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 4 weeks
Setting: recruited from rural junior high and high schools in southeastern Arkansas.
Intervention delivered in health clinics in USA
Trial registration:
Participants Population: 49 adolescents with asthma randomised to tele-pharmacy counselling (n =
24) or written instructions only (n = 25) (control)
Age: across both groups: 12 to 14 years = 43%, 15 to 17 years = 50%, 18 to 19 years =
7%
Baseline asthma severity: not reported
Inclusion criteria: diagnosis of asthma, previous MDI use, male or female adolescents in
grades 7 to 12, access to a local health clinic with interactive compressed video equipment
Exclusion criteria: not reported
Percentage withdrawn: 38% of participants withdrew from the intervention group, and
12% from the control group
Other allowed medication: not reported
Interventions Intervention summary: Participants in the tele-pharmacy counselling group demon-
strated MDI technique at baseline (pretest) during the first session. A pharmacist scored
each performance using theMDI Technique Checklist. Participants received counselling
that included verbal instructions and demonstrations by the pharmacist of any needed
corrections to their MDI technique. Reassessment for MDI technique immediately fol-
lowed counselling (post test). MDI technique was assessed a third time 2 to 4 weeks later
(follow-up). After the final assessment session, additional counselling by the pharmacist
was provided for participants who needed corrections to their MDI technique or for
those who had specific questions about asthma
Control summary: The control group also demonstrated pretest, post-test and follow-
up MDI technique. After completing the pretest assessment, this group received the
“Patient’s Instructions for Use of the Metered-Dose Inhaler” with written instructions
for use of the MDI on a package insert provided with their placebo inhaler. These
written instructions were reproduced from a patient inhaler package insert that included
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diagrams demonstrating proper MDI technique and instructions printed in small type.
Counselling on correct MDI technique was not provided by the pharmacist during
this assessment period. After reviewing the inhaler package insert, participants were
immediately reassessed for MDI technique by the pharmacist. After completion of the
final assessment, verbal instructions and demonstrations by the pharmacist were given
to correct improper MDI technique. Participants in the control group were asked if they
had any questions about asthma at this final session and were instructed accordingly
Outcomes Outcomes measured: MDI inhaler technique, patient satisfaction with intervention
measured using a “Telepharmacy Metered-Dose Inhaler Technique Evaluation instru-
ment” (not previously validated)
Technique assessment method used: MDI Technique Checklist (validated) evaluated
8 skills for proper MDI technique, including preparation of inhaler equipment, position
of the mouth on the inhaler mouthpiece and breathing techniques. Maximum score = 8
Notes Type of publication: single peer-reviewed journal article
Funding: funded by a grant from the Office for the Advancement of Telehealth in the
Department of Health Resources and Services Administration
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ’“The participants in the study were as-
signed to either a tele-pharmacy coun-
selling group or a control group using a ran-
dom number chart”
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No description of procedures intended to
blind outcome assessors to group alloca-
tion; therefore assessment of inhaler tech-
nique may be at risk of detection bias
Incomplete outcome data (attrition bias)
All outcomes
High risk Unbalanced drop-out (38% in the inter-
vention group and 12% in the control
group) may have introduced bias. In addi-
tion, no flow diagram was presented, and
reasons for drop-out were not given, apart
from 8 participants who were excluded as
they had never used an MDI (“Three stu-
dents did not attend any visit, 8 students
had never used an MDI in the past (and,
therefore, did not meet the inclusion crite-
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ria), and 2 students did not attend the fol-
low-up visit for comparison”)
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified.
However, all outcomes listed in Methods
clearly reported in paper
Other bias Low risk None noted
Carpenter 2015
Methods Design: open-label parallel-group randomised controlled trial
Duration: 1 month
Setting:2paediatric practices in amedium-sizedmetropolitan county inNorthCarolina,
USA
Trial registration: NCT01641211
Participants Population: 91 children and adolescents with asthma randomised to inhaler technique
video (n = 46) or an attention control video (n = 45)
Age: mean age (SD) in the intervention group was 10.9 (2.6) years, and in the control
group 10.8 (2.9) years
Baseline asthma severity: intervention group: mild persistent asthma = 52%moderate/
severe asthma = 44%; control group: mild persistent asthma = 49% moderate/severe
asthma = 51%
Inclusion criteria: 7 to 17 years old, could speak English or Spanish, could read the
assent form, were present at the visit with an adult (> 18 years old) caregiver (parent or
legal guardian) who could speak English or Spanish, used an MDI, missed or incorrectly
performed at least 1 step on an inhaler technique assessment, had mild, moderate or
severe persistent asthma
Exclusion criteria: not reported
Percentage withdrawn: 7% of children withdrew from the intervention arm, and 13%
from the control arm
Other allowed medication: not reported
Interventions Intervention summary: 3-minute video in English or Spanish. Separate videos were
available for an MDI with or without a spacer; children who indicated that they had
used anMDI with a spacer and without a spacer watched bothMDI videos. Each inhaler
video provided an overview of the device and specific instructions for how to use the
device correctly. Children watched the videos on a laptop computer and were given a
wallet card with a web address and login information, so they could watch the video
again after leaving the clinic
Control summary: control group: children allocated to an attention control group
in which they watched a 3-minute video about nutrition in English or Spanish. The
nutrition video discussed the importance of balancing protein, carbohydrates and lipids
in one’s diet
Outcomes Outcomes measured: inhaler technique, child inhaler self-efficacy, asthma control
(ACT)
Technique assessment method used: MDI technique was measured as the number of
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steps (out of 8 possible steps) that the child performed correctly. The RA used an inhaler
technique checklist to document whether each step was performed correctly
Notes Type of publication: single peer-reviewed journal article
Funding: This pilot project was supported by Award Number ULTR000083 from the
National Center for Advancing Translational Sciences. Dr Carpenter’s salary was sup-
ported in part by the National Center for Research Resources and the National Cen-
ter for Advancing Translational Sciences, National Institutes of Health, through Grant
KL2TR000084
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The randomisation sequence was pre-
pared ahead of time by a statistician who
used computer-generated random num-
bers. Randomisationwas stratified by clinic
Allocation concealment (selection bias) Low risk Immediately after the child’s medical visit,
the RA opened a sequentially numbered,
sealed envelope to determine whether the
child had been allocated to the experimen-
tal or control group
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The study RA was not blinded to chil-
dren’s experimental group assignment. All
children and caregivers were informed that
the study was about how children use their
asthma devices
Blinding of outcome assessment (detection
bias)
All outcomes
High risk The study RA was not blinded to chil-
dren’s experimental group assignment. All
children and caregivers were informed that
the study was about how children use their
asthma devices
Incomplete outcome data (attrition bias)
All outcomes
Low risk Less than 15% of participants were lost
to follow-up. All randomised participants
were included in the adjusted intention-to-
treat primary analysis
Selective reporting (reporting bias) Low risk The study was prospectively registered as
NCT01641211; outcomes were reported
as planned at all time points
Other bias Low risk None noted
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Donateo 1996
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 1 week
Setting: Italy; setting not reported
Trial registration: not reported
Participants Population: 36 older adults with asthma randomised to MDI with Jet spacer (n = 18)
or MDI without spacer (n = 18)
Age: aged 65 years and older; mean age (SD) years in the intervention group 67.9 (1.6)
, and in the control group 67.6 (1.8)
Baseline asthma severity: mean (SD) PEFR % predicted = 65.4(6) in the intervention
group, and in the control group 65.5 (5)
Inclusion criteria: aged 65 and older, imperfect inhaler technique at baseline, moderate
asthma (PEFR 60% to 80% predicted), reversibility (15%+ increase in FEV1 30 minutes
post 200 mcg salbutamol), ability to co-operate and to be instructed on use of inhalers
Exclusion criteria: airway infection, serious comorbidity, inability to abstain from theo-
phylline or LABA use during study
Percentage withdrawn: 0% of participants withdrew from the intervention group, and
6% from the control group
Other allowed medication: inhaled steroids, inhaled sodium cromoglycate and ne-
docromil were allowed if patients were already receiving these drugs. LABA, oral bron-
chodilators and anticholinergics were not allowed
Interventions Intervention summary: small (approx. 10 cm diameter) spacer device used with MDI.
Intended to reduce need for co-ordination of actuation and inhalation, to reduce oropha-
ryngeal deposition and to increase deposition in lower airways
Control summary: standard MDI without spacer device
Outcomes Outcomes measured: FEV1, PEFR, patient-reported acceptability of device, adverse
events
Technique assessment method used: technique not measured or reported
Notes Type of publication: single peer-reviewed journal article
Funding: not reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as ’randomised’ but no other de-
tails
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
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Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Although no description of procedures in-
tended to blind participants or personnel
to group assignment, outcomes measured
in this study unlikely to be prone to detec-
tion bias and not included in meta-analysis
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 1 participant withdrew from the
study; reason for withdrawal given
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified.
However, all outcomes listed in Methods
clearly reported in paper
Other bias Low risk None noted
Fernandes 2011
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 12 weeks
Setting: “hospital” based, country not stated
Trial registration: not reported
Participants Population: 89 people with asthma randomised to an education intervention group (n
= 43) or a control group (n = 46) (n not stated explicitly for each group; these numbers
are calculated from the percentage female given per group)
Age: mean age (SD) in the intervention group 41 (14) years, and in the control group
41 (12) years
Baseline asthma severity: “uncontrolled” asthma
Inclusion criteria: non-smoking patients with new, uncontrolled asthma reporting to
hospital
Exclusion criteria: not reported
Percentage withdrawn: not reported
Other allowed medication: not reported
Interventions Intervention summary: inhaler technique education delivered by respiratory therapist
(no further details)
Control summary: routine inhaler technique instruction delivered by physician (no
further details)
Outcomes Outcomes measured: inhaler technique and asthma control (ACT)
Technique assessment method used: not described
Notes Type of publication: conference abstract
Funding: not reported
Risk of bias Risk of bias
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Fernandes 2011 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as ’randomised’, but no details
of sequence generation
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment; for patient-reported outcomes,
such as ACT, the participant was the out-
come assessor
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Drop-out not reported
Selective reporting (reporting bias) High risk No prospective trial registration identified.
Minimal details, as reported as conference
abstract only. Unclear what “asthma con-
trol” percentage refers to. Number of par-
ticipants included in analysis unclear
Other bias Low risk None noted
Goodyer 2006
Methods Design: single-blind parallel-group randomised controlled trial
Duration: intervention and assessment on the same day
Setting: GP surgeries in Camden followed by ’snowball’ convenience sampling method
was therefore used; contacts in social clubs and informal networks in Tower Hamlets
and Camden, UK
Trial registration: not reported
Participants Population: 69 Turkish-speaking people with asthma randomised to a multi-media
touch screen system (MTS) (n = 34) or translated patient information leaflet (PIL) plus
support from a translator (PIL + verbal) (n = 35) (PIL + supported treatment as control)
Age: mean (SD) age across both groups 41 (17.5) years
Baseline asthma severity: not reported
Inclusion criteria: Turkish-speaking people with asthma who use an MDI
Exclusion criteria: not reported
Percentage withdrawn: not drop-out
Other allowed medication: not reported
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Goodyer 2006 (Continued)
Interventions Intervention summary: MTS system covered key steps in correct inhaler use and ad-
ditional information on posture. Participant could interact with the programme by se-
lecting to replay a step, or could move on to the next one. Participants were allowed to
use the programme for as long as they wished before repeating the demonstration. The
researcher/translator identified areas where technique could be improved, then spent up
to 15 minutes discussing this with the user
Control summary: Leaflet was produced by one of the trial authors (fluent in Turkish)
and was an exact translation of the current version of Allen and Hanbury’s PIL for
the Ventolin MDI. Participants were allowed to study the leaflet for as long as they
wished before repeating the demonstration. The researcher/translator identified areas
where technique could be improved, then spent up to 15 minutes discussing this with
the user
Outcomes Outcomes measured: inhaler technique
Technique assessment method used: Participants were videotaped while using their
inhaler before and after the intervention. Blinded assessor rated their technique first as
a ’quick check’, then using a checklist
Notes Type of publication: single peer-reviewed journal article
Funding: funded by the Department of Health and the North London Primary Care
Research Network (Nocten)
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ’“Patient allocationwas done using random
number tables”
Allocation concealment (selection bias) Unclear risk ’“Patients did not know in advance which
information method they would receive”
but no description of concealing allocation
from investigators
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel were aware of
group allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “These assessors (of the inhaler technique
videos) did not attend experimental ses-
sions and had no contact with patient vol-
unteers. They were therefore blind as to the
information format”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Study was completed in 1 session, with
technique assessed before and after instruc-
tion. No drop-out
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Selective reporting (reporting bias) Unclear risk No prospective trial registration identified.
Only outcome described in Methods (in-
haler technique) is clearly reported, but
baseline characteristics per arm not given,
so not able to objectively assess for baseline
imbalance
Other bias Low risk None noted
Lirsac 1991
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 15 days
Setting: France; setting not reported
Trial registration: not reported
Participants Population: 45 people with asthma randomised to patient information sheet (group 1)
(n = 14) or video group (group 2) (n = 14) or video + spacer (group 3) (n = 17)
Age: 10 to 71 years; mean (SD) age in group 1: 48 (17) years, in group 2: 35 (19) years
and in group 3: 26 (20) years
Baseline asthma severity: mean (SD) baseline FEV1 (L): group 1: 2.03 (0.65), group
2: 1.89 (0.61), group 3: 1.77 (0.66)
Inclusion criteria: asthma characterised by attacks of paroxysmal dyspnoea with wheez-
ing and a reversible airway obstruction demonstrated in the year preceding inclusion;
using daily MDI, but with imperfect technique; had to speak and understand French,
be cooperative with the study procedure and not be using a spacer device. Treatment of
patients must be stable for 15 days before the start of the study and during the 15 days
of the study
Exclusion criteria: not reported
Percentage withdrawn: no drop-out
Other allowed medication: not reported, although 22 patients were using ICS, and 22
theophylline
Interventions Intervention summaries: Group 1: Participants receivedMDI use education by reading
an information sheet, which included a statement by the doctor and diagrams, for 3 to
4 minutes
Group 2: Participants viewed a 5-minute video describing correct use of the MDI
Group 3: Participants viewed the same film as the video group but extended by 2minutes
to describe the use of a spacer device. Participants were also given a spacer device. This
group was intended to act as a positive control with optimal inhalation technique
Outcomes Outcomes measured: FEV1, inhalation technique score
Technique assessment method used: 4-item checklist
Notes Type of publication: single peer-reviewed journal article (in French)
Funding: not reported
Risk of bias Risk of bias
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Lirsac 1991 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were allocated to 1 of 3 groups
according to a randomisation code, re-
vealed, for each participant, just before the
education
Allocation concealment (selection bias) Low risk “Revealed, for each patient, just before the
education” suggests that this was kept con-
cealed in advance
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No description of procedures intended to
blind outcome assessors to group alloca-
tion; therefore assessment of inhaler tech-
nique may be at risk of detection bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk Appears all participants completed follow-
up
Selective reporting (reporting bias) High risk No prospective trial registration identified.
All outcomes listed in Methods appear to
be reported, but some in graphs, so un-
able to extract. Inhaler technique data for
positive control group also not given, but
likely because use of the spacer device made
this group incomparable with the other 2
groups
Other bias Low risk None noted
Mehuys 2008
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 26 weeks
Setting: 66 community pharmacies, Belgium
Trial registration: not reported
Participants Population: 201 adults with asthma randomised to a pharmacist education intervention
(n = 107) or to usual pharmacy care (n = 94)
Age:mean age (range) in the intervention group 35.2 (19 to 51) years, and in the control
group 36.3 (17 to 51) years
Baseline asthma severity: in the intervention group, 5.6% had an ACT score < 15
(indicating poor control), and in the control group 8.5% had a score < 15
Inclusion criteria: required to carry a prescription for asthmamedication. In consecutive
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Mehuys 2008 (Continued)
order, patients visiting the pharmacy were invited to participate in the study when they
fulfilled the following inclusion criteria: aged between 18 and 50 years; being treated for
asthma for > 12 months; 3) “using” controller medication; and 4) regular visitor to the
pharmacy
Exclusion criteria: smoking history of .10 pack-years, suffering from another severe
disease (e.g. cancer) and with an ACT score at screening of ,15 (indicating seriously
uncontrolled asthma; for ethical reasons, patients were immediately referred to their
general practitioner (GP) or respiratory specialist) or equalling 25 (indicating complete
asthma control; no room for improvement)
Percentage withdrawn: 25% of participants withdrew from the intervention group, and
26% from the control group
Other allowed medication: not reported
Interventions Intervention summary: Before the start of the present study, participating pharmacists
had a training session about asthma (pathophysiology), its non-pharmacological and
pharmacological treatment (GINA guidelines) and use of the study protocol. Participants
in the intervention group received a protocol-defined intervention at the start of the
study and at 1- and 3-month follow-up visits
Control summary: Participants in the control group received usual pharmacist care
Outcomes Outcomes measured: asthma control (ACT), patient diary (nocturnal awakenings due
to the number of inhalations of rescue medication; the best of 3 measurements of peak
expiratory flow), severe asthma exacerbations (defined as those requiring treatment with
oral glucocorticoids (individually recorded in computerised pharmacy records) or an
emergency department visit or hospital admission due to asthma), adherence to med-
ication (prescription refill rates and self-reporting), AQLQ, asthma knowledge inhaler
technique
Technique assessment method used: 10-point checklist for MDI + spacer and 8-point
checklist for DPI (1 point for each correct step, but total score of 0 given in major error
made, e.g. failure to remove cap)
Notes Type of publication: single peer-reviewed journal article
Funding: funding not reported but study authors thank GlaxoSmithKline (GSK) Bel-
gium for permission to use the Asthma Control Test
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The sequence of allocation to either con-
trol or intervention group was predeter-
mined by the investigators based on a ran-
domisation table”
Allocation concealment (selection bias) Low risk “Serially numbered, closed envelopes were
made for each participating pharmacy. The
envelope with the lowest number was
opened by the pharmacist upon inclusion
of a new patient”
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk It was not possible to blind participants, so
some outcomes such as ACT and AQLQ
are subject to potential performance bias,
as participants knew to which group they
were assigned
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Blinding of outcome assessors is not de-
scribed, and it appears that inhalation
technique was assessed by the pharma-
cist delivering the intervention. Other pa-
tient-reported outcomes (such as ACT and
AQLQ) are also at risk because the partic-
ipant was the outcome assessor
Incomplete outcome data (attrition bias)
All outcomes
High risk Approx-
imately 25% of participants dropped out
of each arm of the trial. Although reasons
were similar and baseline characteristics of
those completing and not completing did
not differ significantly, rate of drop-out still
high; we cannot be sure this did not affect
the results. Secondary outcomes were anal-
ysed per protocol rather than by ITT
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified,
although all outcomes listed in Methods
reported in text/tables
Other bias Low risk None noted
Nahafizadeh 2010
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 2 months
Setting: “outpatients”, Iran
Trial registration: not reported
Participants Population: 46 people with asthma randomised to inhaler technique education (n = 25)
or no education/usual care (n = 20)
Age: mean age (SD) across both group 48 (13) years
Baseline asthma severity: “According to ACT score, none of patients were in complete
asthma control at the beginning”
Inclusion criteria: not reported
Exclusion criteria: not reported
Percentage withdrawn: not reported
Other allowed medication: not reported
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Nahafizadeh 2010 (Continued)
Interventions Intervention summary: face-to-face education about proper use of inhalers (no further
details)
Control summary: usual care (no further details)
Outcomes Outcomes measured: asthma control (ACT) and FEV1
Technique assessment method used: inhaler technique not reported
Notes Type of publication: conference abstract
Funding: not reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “randomly placed”; no further details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No description of procedures intended to
blind outcome assessors to group assign-
ment; for patient-reported outcomes, such
as ACT, participant was the outcome asses-
sor
Incomplete outcome data (attrition bias)
All outcomes
Low risk No description of drop-outs but numbers
reported and related percentages suggest
that only 1 person did not complete the
study
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified.
Minimal details, as reported as conference
abstract only. Unclear how “complete con-
trol” is defined. Unclear how many partici-
pants were included in the analyses at each
time point
Other bias Low risk None noted
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Ozkaya 2010
Methods Design: single-blind parallel-group randomised controlled trial
Duration: 12 weeks
Setting: allergy outpatient clinic in the urban area of Istanbul, Turkey
Trial registration: not reported
Participants Population: 130 children with asthma randomised to face-to-face nurse training (n =
66 completed) or no training (package insert) (n = 54 completed). NB: n randomised
to each arm not reported
Age: mean (SD) age in intervention group 8.2 (1.7) years, and in control group 7.7 (0.
9) years
Baseline asthma severity: in the intervention group 51 classified as mild asthma, 15 as
moderate; in the control group 42 classified as mild asthma; 12 as moderate
Inclusion criteria: mild to moderate asthma and attending outpatient allergy clinic.
Diagnosis and severity of asthma defined according to GINA 2005
Exclusion criteria: not reported
Percentage withdrawn: not reported
Other allowed medication: Participants were permitted to take salbutamol or terbu-
taline as needed for relief of symptoms.“None of the patients had previously received an
MDI with spacer, and none had taken oral steroids in the past 1-month”
Interventions Intervention summary: At the beginning of the study, the active group was educated
at home on correct use of the MDI spacer by 2 paediatric nurse specialists certified in
allergy-pulmonology. All of the children in this study group received instruction. All
participants were prescribed fluticasone propionate 125 mg 1 puff by an MDI with a
small-volumeAerochamber spacer twice daily for 12weeks. Educational pamphlets, such
as those on asthma management, prophylactic measures and trigger avoidance, were also
distributed to both groups
Control summary: The control group was left as a baseline, meaning that group mem-
bers did not receive any formal education on correct use of the MDI spacer. However, all
study participants received the Aerochamber package insert, which includes information
on how to use the device. All participants were prescribed fluticasone propionate 125
mg 1 puff by an MDI with a small-volume Aerochamber spacer twice daily for 12 weeks.
Educational pamphlets, such as those on asthma management, prophylactic measures
and trigger avoidance, were also distributed to both groups
Outcomes Outcomes measured: inhalation skill, health-related quality of life (PAQLQ), spirom-
etry. All participants were asked to keep an asthma diary on the presence of asthma
symptoms and on the use of main and additional antiasthmatic drugs
Technique assessment method used: Inhalation skill scoring was done using the stan-
dardised MDI spacer checklist. Summation of 10 item scores not weighted equally
Notes Type of publication: single peer-reviewed journal article
Funding: not reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
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Ozkaya 2010 (Continued)
Random sequence generation (selection
bias)
Unclear risk “Our subjects were randomly classified into
study and control groups at the beginning
of therapy” - no further details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
High risk “At the end of the 12 weeks, a paediatric
allergist blinded to the results of the pul-
monary function parameters (PFPs), rated
each child’s MDI spacer skills after asking
the child to demonstrate how he or she
used the MDI spacer at home”. However,
it is not clear if this outcome assessor was
blinded to group allocation, and for pa-
tient-reported outcomes, such as AQLQ,
the un-blinded participant was the out-
come assessor
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Drop-out not clearly reported (130 chil-
dren were randomised and 120 are in-
cluded in the analyses because 10 dropped
out. eAlthough this represents fairly low
drop-out overall of 7.7%, it is not clear
to which groups the drop-outs were ran-
domised)
Selective reporting (reporting bias) High risk No prospective trial registration identified,
and the PAQLQ is reported only as a corre-
lationwith theMDI checklist, not asmeans
per group
Other bias Low risk None noted
Rahmati 2014
Methods Design: open-label parallel-group randomised controlled trial
Duration: 4 weeks
Setting: “clinics”, Iran
Trial registration: IRCT2013091514666N1
Participants Population: 90 adults with asthma randomised to face-to-face training: non-spacer
group (n = 30) or face-to-face training: spacer group (n = 30) or no training (control) (n
= 30)
Age: mean age (SD) in the non-spacer group was 41.5 (9.1), in the spacer group 42.7
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(13.8) and in the control group 44.7 (10.8)
Baseline asthma severity: not reported; however, mean duration of asthma ranged from
2.6 to 2.8 years across groups (with SD < 1.0), which is surprisingly short given the age
of participants
Inclusion criteria: asthmatic patients who had been referred to the clinics affiliated with
Shiraz University of Medical Science, Shiraz. 18 to 60 years old, with a past history of
using salbutamol MDI for at least 3 months, and not participating in similar interven-
tional programmes
Exclusion criteria: smoking, having an asthmatic attack and not willing to continue co-
operation in the study
Percentage withdrawn: no withdrawals
Other allowed medication: salbutamol
Interventions Non-spacer group:Three educational sessions, both theoretical and practical, were held
for the 2 intervention groups. Inhalation techniques with and without spacer were taught
in the spacer group and the non-spacer group, respectively. Educational classes included
presenting a lecture, showing a PowerPoint, holding a question and answer session and
evaluating participants at the end of the session. The content of instructional sessions in
the non-spacer group included the principles of asthma, the importance and advantages
of correct inhalation technique, training on inhalation technique without using a spacer
and repetition and reinforcement of training presented in 3 sessions
Spacer group: as for non-spacer group but amended to teach correct use of MDI with
a spacer
Control group: Control group did not receive any interventions
Outcomes Outcomes measured: PEFR and inhalation skills
Technique assessment method used: two 11-item checklists for checking MDI usage
skills scored by 0 and 1 (double-rated in advance on 10 participants showing correlation
of 0.95). A separate checklist was used for MDI with and without spacer, and the control
group was assessed on both
Notes Type of publication: single peer-reviewed journal article
Funding: not reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The subjects were randomly divided into
two intervention groups and a control
group using block randomization with a
random sequence of 6 block sizes.”
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk “It should be noted that the patients were
aware of the reasons of the interventions
and the research was not thus blinded”
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Blinding of outcome assessment (detection
bias)
All outcomes
High risk No description of procedures intended to
blind outcome assessors to group alloca-
tion; therefore assessment of inhaler tech-
nique may be at risk of detection bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk No drop-out, no exclusions from the anal-
ysis
Selective reporting (reporting bias) Unclear risk Prospectively registered
trial (IRCT2013091514666N1); all listed
outcomes reported
Other bias Low risk None noted
Rydman 1999
Methods Design: single-blind parallel-group randomised controlled trial
Duration: 8 to 20 weeks
Setting: 1 inner city asthma clinic, part of Cook County Hospital, Illinois
Trial registration: not reported
Participants Population: 68 people with asthma randomised to face-to-face verbal training + demon-
stration (n = 36) or written training (package insert) (n = 32)
Age: mean (SD) age in the intervention group 49.5 (16.5) years, and in the control
group 43.6 (13.5) years
Baseline asthma severity: baseline FEV1 (SD) (L) in the intervention group 2.18 (0.
95), and in the control group 2.05 (0.75)
Inclusion criteria: diagnosed, stable asthmatic patients who had been in the Pulmonary/
Asthma clinic for 6 months
Exclusion criteria: missed more than 25% of appointments in the previous 6 months,
had an ED visit in the month before entry or 2 or more visits in the prior 6 months,
taking more than 10 mg of oral prednisolone daily or 30 mg every other day, unable to
read or understand English
Percentage withdrawn: 11% of participants withdrew from the intervention arm, and
13% from the control arm
Other allowed medication: All participants had access to albuterol in an MDI and
pirbuterol in BAI
Interventions Intervention summary: Experimental group received verbal instructions and demon-
stration on breath actuated inhaler technique. Participants were asked to demonstrate
their inhalation technique to the instructor, who counselled them until their technique
was deemed proper. Also were given written instructions (package insert). Both experi-
mental and control group participants demonstrated theirMDI technique to the instruc-
tor upon enrolment (baseline MDI). The instructor then gave them a demonstration of
MDI technique and counselled them on correct use of the MDI
Control summary: Control group received written instruction only on breath actuated
inhaler use. After receiving instructions, participants also demonstrated their technique to
the instructor, who did not correct them or give feedback if incorrect. Both experimental
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and control group participants demonstrated their MDI technique to the instructor
upon enrolment (baseline MDI). The instructor then gave them a demonstration of
MDI technique and counselled them on correct use of the MDI
Outcomes Outcomes measured: BAI and MDI competency
Technique assessment method used: Scoring was based on competency features re-
peated in scientific literature. Participants had to complete all steps successfully for each
of the respective inhalers to be given a score of 1. If any steps were missed, participants
were given an overall score of zero for that inhaler technique
Notes Type of publication: single peer-reviewed journal article
Funding: funded in part by a grant from 3MPharmaceuticals, St. Paul, Minnesota, USA
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patients were randomized either to an ex-
perimental group or control group in order
to evaluate twodifferent teachingmethods”
- no further details (although randomisa-
tion reported to be ’successful’ owing to lack
of baseline imbalance)
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Patients demonstrated their BAI andMDI
techniques to an independent physician
who was blinded as to their group assign-
ment”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 68 participants were randomised (36 and
32 in experimental and control groups) and
60 were included in the analyses (32 and
28). Hence, 4 participants dropped out
of each group, which was 11.1% and 12.
5% drop-out in intervention and control
groups. These people were not included in
the analysis, but drop-out was low and bal-
anced
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified,
although all outcomes listed in Methods
reported
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Other bias Low risk None noted
Savage 2003
Methods Design: single-blind parallel-group randomised controlled trial
Duration: intervention and assessment on the same day
Setting: 4 GP surgeries in North London, UK
Trial registration: not reported
Participants Population: 110 adults and adolescents with asthma randomised to a multi-media touch
screen system (MTS) (n = 57) or written training (package insert) (n = 48)
Age: aged 12 to 87 years, mean (SD) not given
Baseline asthma severity: 44% of participants in the intervention group BTS step 3
and above; 38% in the control group
Inclusion criteria: Patients over 12 years old, recorded as using a bronchodilator MDI
in the past 6 months, were identified from surgery repeat medication records by the
practice manager
Exclusion criteria: problem patients, those known not to speak English well
Percentage withdrawn: 9% of participants dropped out from the intervention arm, and
10% from the control arm
Other allowed medication: not reported
Interventions Intervention summary: The demonstration on the multi-media touch screen computer
(MTS) covered key information points contained in pictures 1 to 6 of the ‘How to use
your inhaler’ section of the Ventolin patient information leaflet. Key messages given in
the voice-over were reinforced as on-screen text. After each step, the participant could
choose whether to proceed, or to replay a section. At the end, the participant could choose
to repeat a section, or the whole demonstration. This could be done as many times as the
participant wished. Participants were asked to demonstrate how they used their inhaler,
and this was videotaped before and after the participant received information. Remaining
technique errors were discussed and documented, and participants were referred on to
the practice nurse or GP if required
Control summary: The patient information leaflet used was a laminated copy of the
1996 version of the Ventolin pack leaflet. Both MTS and PIL used white male models as
demonstrators. Participants were asked to demonstrate how they used their inhaler, and
this was videotaped before and after the participant received information. Remaining
technique errors were discussed and documented, and participants were referred on to
the practice nurse or GP if required
Outcomes Outcomes measured: global inhaler technique, co-ordination of inspiration and inhaler
actuation, breathing in time, information acceptability and usefulness (agree, neutral,
disagree to a series of 18 statements about information format and content)
Technique assessment method used: Videotaped demonstrations were assessed ‘blind’
by an assessor who did not attend experimental sessions and had no contact with partic-
ipant volunteers. Global technique was rated as poor, adequate or good, and individual
steps were scored as correct/incorrect with the use of a checklist. Inhaler shaking (counts)
and length of inspiration (seconds) were assessed directly from videotaped recordings
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Savage 2003 (Continued)
Notes Type of publication: single peer-reviewed journal article
Funding: funded by the Department of Health and the North London Primary Care
Research Network
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patient allocation was done using random
number tables, and was stratified by age”
Allocation concealment (selection bias) Unclear risk “Patients did not know in advance which
information method they would receive”,
but no description of concealing allocation
from investigators
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “They (videos of participants using the in-
haler) were subsequently assessed ‘blind’ by
an assessor who did not attend experimen-
tal sessions and had no contact with patient
volunteers”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Less than or equal to 10% drop-out in both
groups
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified.
Only outcome described in Methods (in-
haler technique) is clearly reported
Other bias Low risk None noted
Schultz 2012
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 52 weeks
Setting: research clinic at Princess Margaret Hospital for Children, Perth, Australia
Trial registration: not reported
Participants Population: 132 children with asthma randomised to the Funhaler incentive device (n
= 64) or Aerochamber control (n = 68)
Age:median (range) age in the intervention group 4.25 (2 to 7) years, and in the control
group 4.25 (2.1 to 6.9) years
Baseline asthma severity: 100% were receiving ICS at baseline (reduced to 67% in
intervention group and 70% in control group by end of study)
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Schultz 2012 (Continued)
Inclusion criteria: asthma diagnosed by a doctor, prescribed inhaled steroids for treat-
ment of their asthma
Exclusion criteria: known immunodeficiency, chronic lung disease other than asthma,
known allergy to study medication, had been administered systemic steroids in the 2
months before the baseline study visit
Percentage withdrawn: 27% of participants withdrew from the intervention arm, and
6% from the control arm
Other allowed medication: none mentioned as excluded. Participants were allowed to
continue to take salmeterol
Interventions Intervention summary: 1-month run-in: Children were switched to fluticasone if on a
different ICS. Those using a spacer with face mask were instructed to use themouthpiece
instead. Spacer technique was checked and corrected if necessary. Children then received
regular inhaled fluticasone through a Funhaler
Control summary: 1-month run-in: Children were switched to fluticasone if on a
different ICS. Those using a sacer with face mask were instructed to use the mouthpiece
instead. Spacer technique was checked and corrected if necessary. Children then received
regular inhaled fluticasone through a conventional valved spacer (Aerochamber)
Outcomes Outcomes measured: asthma control defined as daytime asthma symptoms less than
twice a week and night-time awakenings less than once a month. For 1 week before every
study visit, parents documented symptoms of cough and wheeze and bronchodilator
use on diary cards. Quality of life (QOL) was measured with the PedsQL 3.0 Asthma
Module questionnaire, based on parental response at each study visit
Technique assessment method used: Proficiency in spacer technique was measured at
the first 4 visits by measuring the amount of salbutamol inhaled from spacer onto a
filter interposed between participant and spacer. Five separate doses of salbutamol were
administered to ensure that a measurable amount of drug was deposited onto the filters
Notes Type of publication: single peer-reviewed journal article
Funding: funded in part by a grant from the NIH: R01 HL70967. The fluticasone used
in the study was supplied by GlaxoSmithKline, Australia. The Funhaler devices used in
the study were sponsored by Visiomed, Australia. Sponsors did not have access to the
data and played no part in analyses or in interpretation of the data
NB: As data were not normally distributed, samples were compared using the Mann-
Whitney U-test
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”After the 1-month run-in period, at the
baseline study visit, subjects were ran-
domised, using the block randomisation
method“
Allocation concealment (selection bias) Unclear risk No details
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Schultz 2012 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
High risk ”No description of procedures intended to
blind participants or personnel to group
assignment and for patient reported out-
comes, such as PedsQL, the participant/ca-
reer is the outcome assessor”
Incomplete outcome data (attrition bias)
All outcomes
High risk “Significantly more subjects dropped out
of the Funhaler group (17 vs 4; P < 0.01)
”, which may have impacted the results. In
addition, it is not always clear how many
participants were included in the analysis
at each time point for quality of life
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified;
although all outcomes listed inMethods are
reported, it is not always clear how many
participants were included in the analysis
Other bias Low risk None noted
Self 1983
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 1 to 16 weeks (mean 6) but no training (control group); not followed up after
initial assessment
Setting: allergy clinic in Memphis, Tennessee, USA
Trial registration: not reported
Participants Population: 29 adults with asthma randomised to face-to-face pharmacist training (n =
9) or video training (n = 10) or no training (package insert) (n = 10)
Age: mean age 39 years across all 3 groups
Baseline asthma severity: 4 participants in each group had previously used the devices
- most were not taking/did not need MDIs
Inclusion criteria: mildly asthmatic adults - “mildly asthmatic”
Exclusion criteria: not reported
Percentage withdrawn: no drop-out
Other allowed medication: not reported
Interventions Face-to-face training: personal instruction by 1 of 2 pharmacists on use of the inhaler
while in the physician’s office
Video training: Participants watched a videotaped programme of instruction produced
by investigators
No training: received only an information sheet reflecting the manufacturer’s direction
and the current literature
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Self 1983 (Continued)
Outcomes Outcomes measured: inhaler technique/effectiveness of instruction
Technique assessment method used: 10-point checklist with equal weight items as-
sessed by the physician
Notes Type of publication: single peer-reviewed journal article
Funding: not reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “We randomly assigned 29 mildly asth-
matic adults” - no further details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Inhaler technique was assessed by a “spe-
cially trained technician”. This was not the
person who delivered the intervention, but
it is not clear if this person knew to which
group each participant belonged
Incomplete outcome data (attrition bias)
All outcomes
Low risk No drop-out
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified.
Only outcome described in Methods (in-
haler technique) is clearly reported, al-
though control group is not followed up
Other bias Low risk None noted
Shah 2014
Methods Design: open-label randomised trial; design not clearly reported
Duration: not reported
Setting: 1 hospital, Evanston, Illinois, USA
Trial registration: not reported
Participants Population: 50 people with asthma randomised to computer training, written training
or no training (n in each group not reported)
Age: not reported
Baseline asthma severity: not reported
Inclusion criteria: not reported
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Shah 2014 (Continued)
Exclusion criteria: not reported
Percentage withdrawn: not reported
Other allowed medication: not reported
Interventions Computer training: Participants completed a “computer based training solution” such
as those at www.use-inhalers.com
Written training: “traditional written instruction on inhaler technique”
No training: “our controls were patients without any training and patients given written
training”
Outcomes Outcomes measured: inhaler technique
Technique assessment method used: “videotapes of patients using their inhalers before
and after training were created and analysed by a fixed rubric and given a score”
Notes Type of publication: conference abstract
Funding: not reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “patients were recruited in a randomized,
unblinded enrolment process.” - no further
details
Allocation concealment (selection bias) High risk “randomized, unblinded enrolment pro-
cess” - implies that allocation was not con-
cealed
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Described as ’unblinded’
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Described as ’unblinded’, although ’Inhaler
technique was assessed by “fixed rubric”,
which may have controlled for some bias,
depending on who was making the assess-
ment and whether they knew what sort of
training the participant had received
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Drop-out not reported
Selective reporting (reporting bias) High risk No prospective trial registration identified.
Minimal details reported as conference ab-
stract only
Other bias Low risk None noted
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Tarsin 2008
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 4 weeks
Setting: Tripoli, Libya. Setting not reported
Trial registration: not reported
Participants Population: 76 people with asthma randomised to face-to-face verbal training + 2Tone
training aid (n = 26) or face-to-face verbal training alone (n = 25) (those with correct
MDI technique were used as a control group; others were randomised to 2 training
groups relevant to this review)
Age: not reported
Baseline asthma severity: not reported
Inclusion criteria: patients with asthma using MDI
Exclusion criteria: not reported
Percentage withdrawn: not reported
Other allowed medication:not reported
Interventions Intervention summary: face-to-face verbal training + 2Tone training aid (no further
details)
Control summary: face-to-face verbal training alone (no further details)
Outcomes Outcomes measured: inhalation flow rate, FEV1, Jones Morbidity Index (JMI) and
Juniper AQLQ
Technique assessment method used: inhalation flow rate through MDI
Notes Type of publication: conference abstract
Funding: not reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as ’randomised’ but no details of
sequence generation
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment; for patient-reported outcomes,
such as QOL, the participant was the out-
come assessor
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Drop -out not reported
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Tarsin 2008 (Continued)
Selective reporting (reporting bias) High risk No prospective trial registration identified.
Minimal details reported as conference ab-
stract only
Other bias Low risk None noted
Toumas-Shehata 2014
Methods Design: parallel-cluster repeated-measures randomised controlled trial; blinding not
stated
Duration: 4 weeks
Setting: 1 community pharmacy, Australia
Trial registration: not reported
Participants Population: 19 pharmacists (101 adult patients) randomised to pharmacist training
+ quantitative inhaler feedback (51 patient participants) or to pharmacist training no
quantitative feedback (50 patient participants) (control)
Age: mean age not reported; age categories given (18 to > 60 years)
Baseline asthma severity: mean (SD) ACQ score in intervention group: 1.6 (0.96),
and in control group 1.7 (1.01)
Inclusion criteria: diagnosis of asthma and aged 18 years or over; currently using a
Turbuhaler (TH) or Accuhaler (ACC) for delivery of preventer asthma medication;
having been on the same asthma medication and dose regimen for a minimum of 1
month
Exclusion criteria: medication not self-administered; inability to speak or understand
English; inability to return for follow-up visit; and/or involved in another clinical trial/
study
Percentage withdrawn: 6% of patient participants withdrew from the intervention
group, and 2% from the control group
Other allowed medication: not reported
Interventions Intervention summary: combination of qualitative and quantitative visual feedback
for DPI inhalers. Training of community pharmacists occurred on an individual basis
with the researcher delivering a 2-hour 1-on-1 training session to each pharmacist in
their own community pharmacy. Intervention group pharmacists were also trained as
per a train-the-trainer approach and an established pharmacist-training programme with
an additional quantitative feedback process. Quantitative feedback involved the use of
a portable hand-held spirometer, which has been developed with the ability to assess
breathing manoeuvres associated with the use of different inhaler devices. It is a prepro-
grammed device that can measure breathing manoeuvres and provides feedback in both
numerical and visual/graphic forms. Actual breathing manoeuvres are then compared
with optimal manoeuvres for a particular inhaler. This allows patients to see exactly
where they are making errors and to what extent. A DVD showing HCPs delivering
inhaler technique education to people with asthma was used to consolidate the training
of pharmacists. Pharmacists also received an update on basic asthma management and
inhaled medications
Control summary: current best practice DPI inhaler technique education utilising qual-
itative visual feedback. Training of community pharmacists occurred on an individual
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Toumas-Shehata 2014 (Continued)
basis, with the researcher delivering a 2-hour 1-on-1 training session to each pharmacist
in their own community pharmacy. Control group pharmacists were trained as per a
train-the-trainer approach and an established pharmacist-training programme. A DVD
showing HCPs delivering inhaler technique education to people with asthma was used
to consolidate the training of pharmacists. Pharmacists also received an update on basic
asthma management and inhaled medications
Outcomes Outcomes measured: asthma control (ACQ), inhaler technique
Technique assessment method used: The inhaler technique was assessed according
to manufacturer-approved checklists. Individuals were considered to use the correct
technique if theywere able to performall steps in the checklist correctly. Inhaler technique
data were represented in 2 ways: proportion of participants with correct technique and
mean number of steps performed correctly for each device
Notes Type of publication: peer-reviewed journal article
Funding: This study was funded by the Australian Postgraduate Award. The DVD was
funded through Australian ResearchCouncil Linkage Project LP LP0882737. Checklists
were developed in collaboration with theNational Prescribing Service, Sydney, Australia,
through funding from the Australian Research Council Linkage Project LP LP0882737
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “19 community pharmacists were recruited
and randomised” - no further details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
High risk ’No description of procedures intended to
blind outcome assessors to group alloca-
tion; therefore assessment of inhaler tech-
nique and asthma control may be at risk of
detection bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk Less than 10% drop-out in both groups
Selective reporting (reporting bias) Unclear risk No prospective trial registration identified;
all outcomes listed in methods reported
Other bias Low risk None noted
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Turgeon 1996
Methods Design: single-blind parallel-group randomised controlled trial
Duration: 26 weeks
Setting: 1 asthma clinic in a paediatric hospital, Canada
Trial registration: not reported
Participants Population: 96 children and adolescents with asthma randomised to nurse training:
interactive with feedback (n = 47) or nurse training: pictorial only (n = 49)
Age:median (range) age in the intervention group was 4.5 (0.75 to 15) years, and in the
control group 5.75 (0.75 to 15) years
Baseline asthma severity: in the intervention group: 57% mild; 32% moderate; 11%
severe asthma; in the control group: 55% mild; 35% moderate; 10% severe asthma
Inclusion criteria: children between 1 and 18 years of age starting aerosol therapy for
the first time
Exclusion criteria: younger than 1 year or older than 18 years, previous teaching session
of technique of aerosol administration, language other than French or English, if another
member of the family suffered from asthma and was using inhalers
Percentage withdrawn: 43% of participants withdrew from both intervention and con-
trol arms
Other allowed medication: not reported
Interventions Intervention summary: Experimental participants received an interactive teaching ses-
sion from the asthma clinic nurse that lasted about 15 minutes. Instruction was given
with picture diagrams provided with inhalation devices by pharmaceutical companies.
This was followed by interactive teaching consisting of immediate correction of faulty
technique displayed by the child and/or parent. All participants received 2 teaching ses-
sions at initial and 1-month visits. Devices were MDIs with an Aerochamber, Nebuhaler
or Venthaler and DPIs with Diskhaler or Turbuhaler
Control summary: Control participants received instruction only by picture diagrams
(didactic teaching) given by another nurse, who had no contact with the experimental
group. All participants received 2 teaching sessions at initial and 1-month visits
Outcomes Outcomes measured: technical ability in inhalation and Likert scales for parental per-
ceptions of treatment at 1, 3 and 6 months (end of study); morbidity assessed at baseline
and at 6 months; morbidity evaluated by a questionnaire derived fromBeck et al, includ-
ing number of asthma attacks, number of hospitalisations and duration of stay, number
of ED visits, numbers of missed school days and disability days (unable to perform usual
activities)
Technique assessment method used: assessed by research assistant through direct ob-
servation of the child and/or parent administering a placebo aerosol. Score was calculated
by using a checklist of essential steps of the technique - 1 point for each correct step.
Number of steps differed between devices, so scores were converted into percentages
Notes Type of publication: single peer-reviewed journal article
Funding: supported by the ’Fondation de l’Hopital Sainte-Justine’ through special fund-
ing from the Fonds de la Recherche en Sante de Quebec (FRSQ) and the Interservice
Club Council (Telethon of Stars) granted to the Group in Evaluative, Clinical and Epi-
demiologic Research at the Ste-Justine Hospital Research Center
Risk of bias Risk of bias
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Turgeon 1996 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients were randomised into experimen-
tal and control groups using a computer
generated list of random numbers”
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Participants were evaluated by a research
assistant who was blind to the teaching as-
signment group at baseline and follow-up
visits, and inhalation technique assessed by
this person was themain outcome reported
Incomplete outcome data (attrition bias)
All outcomes
High risk More than 40% dropped out from both
arms; although they are reported to not dif-
fer significantly from those who completed
in terms of baseline demographics, reason
for drop -out is not given and no flow dia-
gram is presented. No ITT analysis/adjust-
ment for attrition is described
Selective reporting (reporting bias) High risk No prospective trial registration identified.
’Morbidity indices’ were collected during
follow -up (e.g. number of attacks, hospi-
talisation and days of school missed) but
were not fully reported, so could not be in-
cluded in the meta-analysis
Other bias Low risk None noted
Vitari 2013
Methods Design: parallel-group randomised controlled trial; blinding not stated
Duration: 4 weeks
Setting: Comprehensive Lung Center, Pittsburgh, Pennsylvania, USA
Trial registration: not reported
Participants Population: 43 people with asthma randomised to face-to-face demonstration + in-
check simulator (n = 22) or face-to-face demonstration (n = 21)
Age: not reported
Baseline asthma severity: not reported
Inclusion criteria: people with asthma new to the Comprehensive Lung Center
Exclusion criteria: not reported
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Vitari 2013 (Continued)
Percentage withdrawn: 5% of participants withdrew from the intervention arm, and
10% from the control arm
Other allowed medication: not reported
Interventions Intervention summary: usual teaching with demonstrator models plus In-Check to
simulate resistance and measure inspiratory flow for each specific inhaler used
Control summary: usual teaching with demonstrator models
Outcomes Outcomes measured: inspiratory flow, number of correct steps met
Technique assessment method used: In-Check inspiratory flow
Notes Type of publication: conference abstract
Funding: not reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ”Twenty-one subjects were randomized to
traditional teaching (control arm) while 22
received In-Check“ - no further details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No description of procedures intended to
blind participants or personnel to group as-
signment
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk ’No description of procedures intended to
blind outcome assessors to group allocation
but the IN-CHECK device provides an ob-
jective measure of inhalation technique”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Less than 10% drop -out in both groups
Selective reporting (reporting bias) High risk No prospective trial registration identified.
Minimal details as reported as conference
abstract only
Other bias Low risk None noted
ACQ: Asthma Control Questionnaire; ACT: Asthma Control Test; AQLQ: Asthma Quality of Life Questionnaire; AQOL: asthma
quality of life; BAI: breath-activated inhaler; BTS:British Thoracic Society; DPI: dry powder inhaler; ED: emergency department;
FEV1: forced expiratory volume in one second; FVC: forced vital capacity; GINA: Global Initiative for Asthma; HCP: healthcare
practitioner; ICS: inhaled corticosteroids; IF: inspiratory flow; ITT: intention-to-treat; IVC: inspiratory vital capacity; JMI: Jones
Morbidity Index; LABA: long-acting beta2-agonist; MDI: metered dose inhaler; MTS: multi-media touch screen system; PACQLQ:
PAQLQ completed by parents of children; PAQLQ: Paediatric Asthma Quality of Life Questionnaire; PEFR: peak expiratory flow
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rate; PIF: peak inspiratory flow; PIL: patient information leaflet; pMDI: pressurised metered dose inhaler; QOL: quality of life; RA:
research assistant; SD: standard deviation; TH: Trainhaler; VC: verbal counselling.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Andres Jacome 2003 Not an RCT
Azouz 2015 Cross-over study performed during 1 clinic visit. Participants used 2 different inhaler types in a randomised
order before and after normal, and then enhanced training with the IN-CHECK device. Before-and-after
data presented only
Basheti 2005a Intervention delivered to pharmacists; focus was pharmacists’ knowledge rather than participant outcomes
Bosnic-Anticevich 2010 Mixed population with asthma and COPD; no disaggregated data presented
Compton 2000 Healthy participants
Eakin 2015 Preliminary observational findings from a complex educational intervention. Primary focus of intervention
not inhaler technique
Epstein 2001 Not an RCT
Eriksson 1980 Trial of impact of spacer delivery on bronchodilatation outcomes
Fornell 2014 Primary focus of intervention not inhaler technique
Garcia-Cardenas 2013 Primary focus of intervention not inhaler technique
Grover 2016 Primary focus of intervention not inhaler technique
Hesselink 2004 Mixed population with asthma and COPD; no disaggregated data presented
Hodges 1981 Trial of impact of spacer delivery on bronchodilatation outcomes
Horner 2008 Primary focus of intervention not inhaler technique
Jolly 2012 Not stated that participants had asthma; likely mixed population with asthma and COPD judging by age
and sex of participants
Jolly 2015 Mixed population with asthma and COPD; no disaggregated data
Kritikos 2007 Primary focus of intervention not inhaler technique
Lee 2010 Not an RCT
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(Continued)
McElnay 1989 Randomised portion of trial involved healthy volunteers
Mulloy 1996 Primary focus of intervention not inhaler technique
NCT01426581 Mixed population with asthma and COPD; no disaggregated data
NCT01456494 Mixed population with asthma and COPD; no disaggregated data
NCT01641211 Subanalysis of a larger trial investigating a multi-faceted intervention to improve asthma management in
older adults. Primary focus of intervention not inhaler technique
NCT02046759 Primary focus of intervention not inhaler technique
NCT02307669 Primary focus of intervention not inhaler technique
NCT02363192 Primary focus of intervention not inhaler technique
NCT02715219 Primary focus of intervention not inhaler technique
Pedersen 1983 Primary focus of intervention not inhaler technique
Poureslami 2016 Primary focus of intervention not inhaler technique
Rachelefsky 1986 Cross-over study of spacer drug delivery
Reiser 1986 Cross-over study primarily assessing impact of spacer delivery on lung function
Sandos Dde 2010 Not an RCT
Schacer 2005 Control group but no mention of random allocation
Tuazon 2002 Primary focus of intervention not inhaler technique
Verver 1996 Mixed population with asthma and COPD; no disaggregated data
WIlliams 1983 Not an RCT - children used as their own controls
Wong 1995 Trial of impact of spacer delivery on bronchodilatation outcomes
Yoon 1993 Primary focus of intervention not inhaler technique
COPD: chronic obstructive pulmonary disease; RCT: randomised controlled trial.
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Characteristics of studies awaiting assessment [ordered by study ID]
NCT02062463
Methods Open-label parallel-group randomised controlled trial
Participants Adults with asthma aged 18 to 75 years receiving step 3 or 4 therapy for asthma as defined by British Thoracic Society
(BTS) guidelines (daily doses of BDP-equivalent ICS ≥ 800 mcg to 2000 mcg as part of fixed or free combinations
with long-acting beta-agonists (LABAs))
Interventions Comparison of inhaler technique mastery of Spiromax vs Symbicort Turbohaler
Outcomes Critical and number of errors, adherence, patient satisfaction, exacerbations, change in asthma treatment, adverse
events
Notes Study reported as completed in March 2015, but no study results posted on clinicaltrial.gov; we are unable to link
record to a full-text publication
Westhus 1998
Methods Quasi-experimental study; a convenience sample of children were “randomly assigned to one of two equal groups”
Participants Children (7 to 12 years of age) with asthma; sample included 154 children (African American and Caucasian)
Interventions Mnemonic device to assist in learning to use the MDI (3 colourful cards with keywords and animated pictures
representing MDI use)
Outcomes At 2 points in time, participants answered demographic and medical history questions, had their inhaler technique
evaluated, receivedmnemonic or standard instructions and performed pulmonary function tests. An inhaler checklist
measured skill in MDI use
Notes Not clear from the abstract whether this is a truly randomised study. Attempted to contact NKWesthus (lead author)
via the University of St Louis; email sent on 26 August 2016; no response received at the time of publication
BDP: beclomethasone dipropionate; BTS: British Thoracic Society; ICS inhaled corticosteroids; LABA: long-acting beta-agonist; MDI:
metered dose inhaler.
Characteristics of ongoing studies [ordered by study ID]
ACTRN12610000159055
Trial name or title Assessing the effectiveness of Inhaler Technique Labels on asthma patients’ inhaler technique
Methods Parallel-group randomised controlled trial
Participants People aged 14 to 85 years with a doctor diagnosis of asthma, currently using inhaled corticosteroids with or
without long-acting beta-agonists via Turbuhaler or Diskus, who have been on the same asthma medication
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ACTRN12610000159055 (Continued)
and dose for a minimum of 1 month before study enrolment. Planned recruitment 214 participants
Interventions Inhaler technique labels used as part of inhaler technique education (verbal plus physical demonstration)
compared with inhaler technique education alone
Outcomes Inhaler technique, asthma control (using Asthma Control Test)
Starting date 01/08/2009
Contact information Dr Iman Amin Basheti
940344
Amman
11194
Jordan
Email: ibasheti@usyd.edu.au
Notes Listed as ’active but not recruiting’. Unable to link to a full-text publication
JPRN-UMIN000006739
Trial name or title The relationship between asthma management and inhaler technique training
Methods Parallel-group randomised controlled trial
Participants Adults with asthma aged 20 years and older with an ACT score under 24. Planned recruitment 90 participants
Interventions No inhaler technique training vs inhaler technique training vs inhaler technique training and education
Outcomes Adherence, ACT, FEV1, FeNO
Starting date 01/11/2011
Contact information Kumiya Sugiyama
880 Kita-kobayashi
Mibu Tochigi
321-0293
Japan
Email: sugiyama@dokkyomed.ac.jp
Notes Status listed as ’enrolling by invitation’. Unable to link to a full-text publication
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NCT01529697
Trial name or title A protocol for a randomised clinical trial of the effect of providing feedback on inhaler technique and adherence
from an electronic device in patients with poorly controlled severe asthma
Methods Single-blind prospective parallel-group randomised clinical trial
Participants Patients with partially controlled or uncontrolled severe asthma who have also had at least 1 severe asthma
exacerbation in the prior year are eligible to participate. Planned recruitment 220 participants
Interventions Active group will receive feedback on their inhaler technique and adherence with the new device over a
3-month period. Control group will also receive training in inhaler technique and strategies to promote
adherence, but no feedback from the device
Outcomes Adherence, inhaler technique, number who remain poorly controlled despite appropriate technique
Starting date 2011
Contact information Imran Sulaiman
Email: imransulaiman@rcsi.ie
Notes
NCT02203266
Trial name or title A randomised, parallel-group, multi-centre trial using a novel ’INCA’ Tracker Device to measure and monitor
compliance and technique of Seretide Diskus inhaler in a community pharmacy setting
Methods Open-label parallel-group randomised controlled trial
Participants Adults with asthma or COPD aged 18 years or older with a valid prescription for Seretide Diskus inhaler or
currently using a Seretide Diskus inhaler. Planned recruitment 200 participants
Interventions Feedback on the participant’s own inhaler use, with personalised information on participant technique and
timing of use of the Diskus inhaler as recorded on the INCA device, will be provided to participants in the
feedback group after 1, 2 and 6 months vs current best practice inhaler technique education
Outcomes Adherence, inhaler technique, rescue inhaled medication use, rescue antibiotic/steroid use, quality of life
Starting date February 2014
Contact information Richard Costello
Royal College of Surgeons
Clinical Research Centre
Beuamont Hospital
Email: rcostello@rcsi.ie
Notes
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NCT02283008
Trial name or title Evaluating the efficacy of 2 different educational strategies for improving and maintaining inhaler technique
Methods Open-label parallel-group randomised controlled trial
Participants Adults aged 35 to 90 years whose regular treatment requires inhaled medication. They will be included
regardless of age, disease, inhaler device used or cognition
Interventions Structured education on the use of inhalers vs usual standard informal education
Outcomes Inhaler technique
Starting date December 2014
Contact information Steven Hickey, Respiratory Nurse Specialist
Northampton General Hospital NHS Trust
Notes
NCT02611531
Trial name or title Video vs Teach-To-Goal Respiratory Inhaler Technique Assessment and InstructioN (V-TRaIN)
Methods Single-blind (outcomes assessor) parallel-group randomised controlled trial
Participants Adults aged 18 years and older, admitted to the inpatient medical service and surgical service with physician-
diagnosed COPD or asthma. We will enrol patients even if the primary reason for admission is not COPD
or asthma (e.g. patients admitted for heart failure but with a physician diagnosis of COPD are eligible)
Interventions Those in the TTG condition will be provided with an intensive, iterative education and evaluation strategy.
Those in the video module education condition will be provided with a tablet device and instructions on how
to complete video training and self-assessment
Outcomes Inhaler technique, symptoms, quality of life, self-efficacy, healthcare utilisation, lung function
Starting date November 2015
Contact information Susannah Butters
Email: sbutters@medicine.bsd.uchicago.edu
Notes
ACT: Asthma Control Test; COPD: chronic obstructive pulmonary disease; FeNO: fractional exhaled nitric oxide; FEV1: forced
expiratory volume in one second; TTG: teach-to-goal.
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D A T A A N D A N A L Y S E S
Comparison 1. Adults: enhanced education versus control/usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Correct inhaler technique (at
follow-up)
3 258 Odds Ratio (M-H, Random, 95% CI) 5.00 [1.83, 13.65]
2 Inhaler technique score Other data No numeric data
3 Asthma control 2 247 Std. Mean Difference (IV, Random, 95% CI) 0.48 [-0.29, 1.24]
4 Asthma control 2 134 Odds Ratio (M-H, Random, 95% CI) 3.18 [1.47, 6.88]
5 Exacerbations requiring at least
OCS
1 Odds Ratio (M-H, Random, 95% CI) Subtotals only
6 Exacerbations requiring ED/
hospitalisation
1 Odds Ratio (M-H, Random, 95% CI) Subtotals only
7 Quality of life 2 247 Std. Mean Difference (IV, Random, 95% CI) 0.52 [-0.04, 1.09]
8 Subgroup analysis: inhaler
technique (at follow-up): to
whom intervention is delivered
3 258 Odds Ratio (M-H, Random, 95% CI) 5.00 [1.83, 13.65]
8.1 Delivered to participants 2 174 Odds Ratio (M-H, Random, 95% CI) 3.03 [1.61, 5.68]
8.2 Delivered to pharmacists 1 84 Odds Ratio (M-H, Random, 95% CI) 12.38 [4.04, 37.90]
9 Subgroup analysis: asthma
control: to whom intervention
is delivered
2 247 Std. Mean Difference (IV, Random, 95% CI) 0.48 [-0.29, 1.24]
9.1 Delivered to participants 1 150 Std. Mean Difference (IV, Random, 95% CI) 0.10 [-0.22, 0.42]
9.2 Delivered to pharmacists 1 97 Std. Mean Difference (IV, Random, 95% CI) 0.88 [0.46, 1.30]
10 Subgroup analysis: inhaler
technique (at follow-up): off-
off vs repeated sessions
3 258 Odds Ratio (M-H, Random, 95% CI) 5.00 [1.83, 13.65]
10.1 One-off 1 24 Odds Ratio (M-H, Random, 95% CI) 3.5 [0.50, 24.56]
10.2 Repeated 2 234 Odds Ratio (M-H, Random, 95% CI) 5.64 [1.40, 22.66]
Comparison 2. Children: enhanced education versus control/usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Correct inhaler technique (at
follow-up)
2 175 Odds Ratio (M-H, Random, 95% CI) 1.29 [0.70, 2.36]
2 Inhaler technique (PIF
immediately after intervention)
1 Mean Difference (Random, 95% CI) Totals not selected
3 Inhaler technique (PIF at follow-
up)
1 Mean Difference (Random, 95% CI) Totals not selected
4 Subgroup analysis: inhaler
technique (at follow-up): one-
off vs repeated sessions
2 175 Odds Ratio (M-H, Random, 95% CI) 1.29 [0.70, 2.36]
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4.1 One-off 1 120 Odds Ratio (M-H, Random, 95% CI) 1.37 [0.66, 2.83]
4.2 Repeated 1 55 Odds Ratio (M-H, Random, 95% CI) 1.11 [0.37, 3.38]
Comparison 3. Adults: multi-media training versus control/usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Correct inhaler technique
(immediately after
intervention)
2 164 Odds Ratio (M-H, Random, 95% CI) 2.15 [0.84, 5.50]
2 Correct inhaler technique (at
follow-up)
1 Odds Ratio (M-H, Random, 95% CI) Totals not selected
3 Inhaler technique score Other data No numeric data
Comparison 4. Children: multi-media training versus control/usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in inhaler technique
score
Other data No numeric data
2 Asthma control (change from
baseline)
1 Mean Difference (IV, Random, 95% CI) Subtotals only
3 Asthma control (endpoint) 1 Mean Difference (IV, Random, 95% CI) Subtotals only
Comparison 5. Adults: feedback device versus control/usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Inhaler technique (PIF) 1 Odds Ratio (M-H, Random, 95% CI) Totals not selected
2 Correct inhaler technique (at
follow-up)
1 Odds Ratio (M-H, Random, 95% CI) Subtotals only
3 Inhaler technique score Other data No numeric data
4 Asthma control 1 Mean Difference (IV, Random, 95% CI) Subtotals only
5 Quality of life 2 100 Mean Difference (IV, Random, 95% CI) 0.38 [-0.01, 0.77]
6 Quality of life (responders) 1 Odds Ratio (M-H, Random, 95% CI) Subtotals only
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Comparison 6. Children: feedback device versus control/usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Inhaler technique (PIF) 2 98 Mean Difference (IV, Random, 95% CI) -9.22 [-33.71, 15.
27]
2 Asthma control 2 98 Mean Difference (IV, Random, 95% CI) -0.02 [-0.35, 0.32]
3 Quality of life (change from
baseline)
2 91 Mean Difference (IV, Random, 95% CI) 0.25 [-0.07, 0.58]
4 Quality of life (endpoint) 1 Mean Difference (IV, Random, 95% CI) Subtotals only
A D D I T I O N A L T A B L E S
Table 1. Summary of characteristics of studies in comparisons 1 and 2: inhaler technique education
Study ID Total n Study dura-
tion
(weeks)
Age Country Interven-
tion
Control In-
haler tech-
nique mea-
sure
Outcomes
Agertoft
1998
72 2 Chil-
dren aged 3
to 5 years
Denmark Instruc-
tional video
+ individual
training; de-
livered to
participant
Instruc-
tional video
PIF PIF,
IVC, PEFR,
FEV1, FVC
Basheti
2005
26 2 Adults Australia Group B:
verbal coun-
selling
Group C:
verbal coun-
selling +
phys-
ical demon-
stration; de-
livered to
participant
Group A:
printed ma-
terials
9-Step Tur-
buhaler
checklist
Inhaler tech-
nique
Basheti
2008
31 pharma-
cists, 97 par-
ticipants
26 Adults Australia Pharmacist-
participant
education +
inhaler tech-
nique labels;
delivered to
pharmacist
Peak flow
measure-
ment train-
ing
9-Step
checklist
Inhaler tech-
nique,
asthma
severity,
peak flow
variability,
AQOL, per-
ceived con-
trol
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Table 1. Summary of characteristics of studies in comparisons 1 and 2: inhaler technique education (Continued)
Bynum
2001
49 4 Adolescents
aged 12 to
19 years
USA Telephar-
macy coun-
selling;
delivered to
participant
Writ-
ten instruc-
tions only
8-Step MDI
checklist
Inhaler tech-
nique, par-
ticipant sat-
isfaction
Fernandes
2011
89 12 Adults Not
reported
Respi-
ratory ther-
apist educa-
tion; deliv-
ered to par-
ticipant
Ro-
tuine physi-
cian educa-
tion
Not
reported
Inhaler tech-
nique,
asthma con-
trol
Mehuys
2008
201 26 Adults Belgium Pharmacist
education;
delivered to
pharmacist
Usual phar-
macy care
10-
Step MDI +
spacer
checklist/
8-step DPI
checklist
Inhaler tech-
nique, ACT,
exacerba-
tions, ED/
hospital
visits, adher-
ence,
AQLQ,
asthma
knowledge
Nahafizadeh
2010
46 8.7 Adults Iran Face-to-
face educa-
tion; deliv-
ered to par-
ticipant
Usual
care (no fur-
ther details)
Not
reported
ACT, FEV1
Ozkaya
2010
130 12 Children Turkey Face-
to-face nurse
training; de-
livered to
participant
Inhaler
package in-
sert only
10-Step
MDI check-
list
Inhaler tech-
nique,
PAQLQ,
spirometry
Rahmati
2014
90 4 Adults Iran Face-to-face
training (no
spacer de-
vice); deliv-
ered to par-
ticipant
Usual care
(no
training)
11-Step
MDI check-
list
Inhaler tech-
nique,
PEFR
Rydman
1999
68 8 to 20 Adults USA Face-to-
face training
+ demon-
stration; de-
livered to
Inhaler
package in-
sert only
Checklist,
converted to
score out of
1 (0 if any
steps
BAI and
MDI com-
petency
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Table 1. Summary of characteristics of studies in comparisons 1 and 2: inhaler technique education (Continued)
participant missed)
Self 1983 29 1 to 16
(mean 6)
Adults USA Face-
to-face phar-
macist train-
ing; deliv-
ered to par-
ticipant
Inhaler
package in-
sert only
10-Step
checklist
Inhaler tech-
nique,
“effective-
ness of in-
struction”
Turgeon
1996
96 26 Children
and adoles-
cents (max
15 years)
Canada Interactive
nurse train-
ing with
feedback;
delivered to
participant
Pictorial
nurse train-
ing only
Checklist
with scores
converted to
percentages
Inhaler tech-
nique,
parental per-
ceptions of
treatment,
asthmamor-
bidity (e.g.
no. of exac-
er-
bations, ED
visits, hospi-
tali-
sations, days
of schools
missed)
ACT: Asthma Control Test; AQLQ: Asthma Quality of Life Questionnaire; AQOL: asthma quality of life; BAI: breath-activated
inhaler; DPI: dry powder inhaler; ED: emergency department; FEV1: forced expiratory volume in one second; FVC: forced vital
capacity; IVC: inspiratory vital capacity; MDI: metered dose inhaler; PAQLQ: paediatric AQLQ; PEFR: peak expiratory flow rate;
PIF: peak inspiratory flow
Table 2. Summary of characteristics of studies in comparisons 3 and 4: multi-media training
Study ID Total n Study dura-
tion (weeks)
Age Country Interven-
tion
Control Inhaler
technique
measure
Outcomes
Acosta 2009 133 4 Adults USA Inhaler tech-
nique train-
ing video; de-
livered to
participant
Asthma edu-
cation video
Not reported “Correct us-
age” of in-
haler
Arthurs
2014
21 13 Children Ireland Inhaler tech-
nique DVD;
delivered to
participant
Individual
instruction
New inhaler
technique
measure-
ment tool
Inhaler tech-
nique, self-
effi-
cacy, knowl-
edge acquisi-
tion
93Interventions to improve inhaler technique for people with asthma (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 2. Summary of characteristics of studies in comparisons 3 and 4: multi-media training (Continued)
Boone 2002 36 4.3 Children UK Inhaler tech-
nique educa-
tional com-
puter soft-
ware (“Space
Inhalers”)
; delivered to
participant
Placebo soft-
ware
15-Step
checklist
Inhaler tech-
nique,
asthma
knowledge
Carpenter
2015
91 4.3 Children and
adolescents
USA Inhaler tech-
nique video;
delivered to
participant
Attention
control video
(about nutri-
tion)
8-Step
checklist
Inhaler tech-
nique, self-
efficacy,
ACT
Goodyer
2006
69 Outcomes
assessed im-
mediately
Adults UK
(Turkish-
speaking
population)
Multi-media
touch screen
training; de-
livered to
participant
Patient infor-
mation
leaflet plus
verbal train-
ing
Inhaler
checklist
Inhaler tech-
nique
Lirsac 1991 45 2.1 Adults and
children (10
to 71 years)
France Inhaler tech-
nique video
OR
inhaler tech-
nique video +
spacer; deliv-
ered to par-
ticipant
Patient infor-
mation sheet
4-Step
checklist
Inhaler tech-
nique, FEV1
Savage 2003 110 Outcomes
assessed im-
mediately
Children and
adults (12 to
87 years)
UK Multi-media
touch screen
training; de-
livered to
participant
Patient infor-
mation
leaflet
In-
haler check-
list, global as-
sessment of
technique
Inhaler tech-
nique,
acceptability
Self 1983 29 1 to 16
(mean 6)
Adults USA Video train-
ing; delivered
to
participant
Inhaler pack-
age insert
only
10-Step
checklist
Inhaler tech-
nique, “ef-
fectiveness of
instruction”
Shah 2014 50 Not reported Not reported USA Computer
training; de-
livered to
participant
Written
training OR
no training
“Fixed
rubric” used
to give a score
Inhaler tech-
nique
ACT: Asthma Control Test; DVD: digital versatile disc; FEV1: forced expiratory volume in one second
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Table 3. Summary of characteristics of studies in comparisons 5 and 6: add-on/feedback device
Study ID Total n Study dura-
tion
(weeks)
Age Country Interven-
tion
Control In-
haler tech-
nique mea-
sure
Outcomes
Al-Showair
2007
108 6 Adults UK Verbal train-
ing + 2Tone
trainer;
delivered to
participant
Verbal train-
ing alone
PIF PIF, FEV1,
AQLQ
Ammari
2013
56 6 Adults and
children
(4 to 55
years)
UK Verbal train-
ing + 2Tone
trainer;
delivered to
participant
Verbal train-
ing alone
PIF PIF, FEV1,
AQLQ/
PAQLQ
Ammari
2015
80 12 Children UK AeroCham-
ber Plus
with Flo-Vu;
delivered to
participant
AeroCham-
ber Plus
alone
PIF PIF,
PAQLQ,
ACQ, par-
ent spacer
preference
Ammari
2015a
30 6 to 8 Children Not
reported
Verbal
training and
use of Train-
haler; deliv-
ered to par-
ticipant
Verbal train-
ing alone
PIF PIF, ACQ
Rahmati
2014
90 4 Adults Iran Face-to-
face training
(with spacer
device)
; delivered to
participant
Usual care
(no
training)
11-Step
MDI check-
list
Inhaler tech-
nique,
PEFR
Schultz
2012
132 52 Children Australia Funhaler in-
cen-
tive device;
delivered to
participant
AeroCham-
ber device
Filter
used to mea-
sure salbuta-
mol deposi-
tion
Inhaler tech-
nique,
asthma con-
trol, quality
of life
Tarsin 2008 76 4 Not
reported
Libya Verbal train-
ing + 2Tone
trainer;
delivered to
participant
Verbal train-
ing alone
PIF PIF, FEV1,
AQLQ,
Jones Mor-
bidity Index
(JMI)
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Table 3. Summary of characteristics of studies in comparisons 5 and 6: add-on/feedback device (Continued)
Toumas-
Shehata
2014
19 pharma-
cists
(101 partici-
pants)
4 Adults Australia Verbal train-
ing +quanti-
tative
inhaler feed-
back; deliv-
ered to phar-
macist
Verbal train-
ing alone
In-
haler check-
list/pro-
portion with
correct tech-
nique
Inhaler tech-
nique, ACQ
Vitari 2013 43 4 Not
reported
USA Face-to-face
demonstra-
tion + In-
Check simu-
lator; deliv-
ered to par-
ticipant
Face-to-
face demon-
stration
PIF, inhaler
checklist
PIF, inhaler
technique
ACQ: Asthma Control Questionnaire; AQLQ: Asthma Quality of Life Questionnaire; FEV1: forced expiratory volume in one second;
MDI: metered dose inhaler; PAQLQ: paediatric AQLQ; PEFR: peak expiratory flow rate; PIF: peak inspiratory flow
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As described, we were unable to perform most of our planned subgroup and sensitivity analyses owing to data paucity.
We planned to contact trial authors to ask for missing information, but owing to the number of included studies and the relatively
small size of individual studies, we did not do so.
97Interventions to improve inhaler technique for people with asthma (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
